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GENERAL ABSTRACT 
 Antral ovarian folliculogenesis involves recruitment of a cohort of small follicles, physiological 
selection of a dominant follicle, and ovulation. The mechanism of selection has not been precisely 
determined. Identification of the timing of preovulatory selection is a key component in understanding 
natural and peri-menopausal ovarian function, ovarian suppression for contraception, and 
improvement of ovarian stimulation protocols. Morphologic characteristics obtained by 
ultrasonography cannot be precisely quantitated by the human eye. Computer-assisted image analysis 
overcomes subjective human evaluation of ultrasonographic images. 
The objectives of this research were to assess ultrasound image attributes of human dominant 
(DF) and 1st subordinate (SF1) ovarian follicles during natural menstrual cycles and following 
discontinuation of conventional and continuous oral contraceptives (OC). We utilized sophisticated 
computer algorithms to elucidate an association between image attributes and physiologic status of 
follicles. Transvaginal ultrasonographic images obtained in 2 previous studies were used to quantify 
changes that occur in ovarian follicles.  
We detected quantitative differences between the dominant and largest subordinate follicles of 
ovulatory and major anovulatory follicular waves, as well as during the first wave following OC 
discontinuation. Differences in ultrasonographic image attributes were associated with the physiological 
status of follicles. Evidence of follicular dominance in follicles which develop during major ovulatory 
waves or following OC discontinuation can be detected prior to the time of selection manifest by 
differences in dominant and subordinate follicle diameters. In addition, differences in quantitative 
image attributes were detected between ovulatory and anovulatory DF. Follicles that develop following 
conventional and continuous OC administration schemes exhibit the same image characteristics.   
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Further research is necessary to elucidate the exact correlation of follicle image attributes during 
all stages of development with histological characteristics, prediction of the timing of DF selection and 
the effects of different OC formulations on follicle development during and following OC cessation. 
Computer-assisted image analysis of ultrasound images has the potential to develop into a diagnostic, 
prognostic, and research tool for the in vivo evaluation of ovarian physiology and pathology and 
elucidate biologically important times such as physiologic selection, ovulation of DF and 
characterization of abnormal follicles (i.e., follicular cysts, luteinized unovulated follicles).  
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Chapter 1 
1. GENERAL INTRODUCTION 
1.1 Human ovarian follicular dynamics 
The first concepts of human reproduction were described in the Aristotelian doctrine. 
Aristotle believed that the egg was formed in the uterus as a consequence of menstrual blood 
activation by the male semen. During the seventeenth century, Jan Swammerdam and Johannes Van 
Horne of Leiden and Niels Stensen of Copenhangen independently developed the new idea that the 
female “testes”, like the ovaries of birds, were the sites of egg formation [1]. Their works were never 
formally published. Later, a Dutch anatomist, named Regnier de Graaf (1641-1673) provided the 
first descriptions of the mammalian female gonad after making a comprehensive study. He wrote: 
The common function of the female testicles is to generate eggs, foster them and bring them to maturity. Thus, in 
women, they perform the same task as do the ovaries of birds. Hence they should be called women’s ovaries 
rather than testicles, especially as they bear no similarity either in shape or content to the male testicles properly 
so-called. On account of this lack of similarity they have been regarded by many as bodies without function; 
quite wrongly, because they are absolutely essential for generation [2]. 
Albrecht von Haller (1708-1777) subsequently named the ovarian follicle after de Graaf 
despite the fact that he made an error in defining of the fluid-filled follicle as an egg. Later in 1827, 
Carl Ernst von Baer described the true ova of mammals as the follicle-enclosed "ovulum". The 
history of reproductive research shows that considerable progress was made in spite of the technical 
limitations and erroneous observation, and that these early studies have provided the foundation for 
this field. 
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1.1.1 Human ovarian anatomy 
The ovaries are dull white, paired ovoid structures which have an average volume of 11 cm3 
in reproductively mature women [3]. The ovary develops from the genital ridge (the ventral cranial 
mesonephrone) in vertebrate embryos. Germ cells originate in the yolk sac, then migrate to the 
ovary during early gestation (6 weeks) [1]. In embryonic and early fetal life, the ovaries are located in 
the lumbar region. They gradually descend to the lesser pelvis, and lie on each side of uterus close to 
the lateral wall. Each ovary has lateral and medial surfaces, superior and inferior extremities, and 
anterior and posterior borders. The suspensory ligament, a peritoneal fold of the ovary, is attached 
to the upper part of the lateral surface of the ovary and contains the ovarian vessels and nerves. The 
ovarian ligament attaches the medial aspects of the ovary to the lateral angle of the uterus and 
contains some smooth muscle cells. The ovarian ligament is continuous with the medial border of 
the round ligament. The mesoovarium, a short peritoneal fold, attaches the ovary to the back of the 
broad ligament and carries blood vessels and nerves to the ovarian hilum. Thus, the ovary nestles in 
the posterior wall of the broad ligament and is connected to the fimbriated end of the fallopian 
tubes [1]. 
The ovarian arteries originate from the abdominal aorta below the renal arteries and supply 
the ovaries, the uterine tubes, the labium majus and the inguinal region [3]. The ovarian veins 
emerge from the ovary as a plexus then form 2 ovarian veins which ascend with the ovarian arteries. 
They enter the inferior vena cava on the right side and into the renal vein on the left side. Lymph 
vessels ascend along the ovarian arteries to preaortic and lateral nodes via 3 main routes. The 
ovarian neural plexuses are comprised of postganglionic sympathetic, parasympathetic and visceral 
afferent fibres. Efferent sympathetic fibres emerge from the tenth and eleventh thoracic spinal 
segment and are vasoconstrictory. Parasympathetic fibres are derived from the inferior hypogastric 
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plexuses and are probably vasodilatory. The nerves follow the ovarian artery to the ovary and uterine 
tube [3]. 
The mature human ovary consists of an outer zone, the cortex, and an inner zone, the 
medulla. A specialized mesothelium (the surface epithelium) covers the ovarian cortex. It contains 
an outer strip of connective tissue, the tunica albuginea and an inner zone that contains the follicles 
[3]. After puberty in a young female, the ovary consists of: 1) surface epithelium; 2) cortex; and, 3) 
medulla. The major part of ovary forms from the cortex. The cortex contains follicles at different 
stages of development, corpora lutea and atretic follicles depending on the age of the women and 
stage of the menstrual cycle. The follicles are embedded in a stroma which is primarily comprised of 
collagen fibres. The central part of the ovary is called the medulla. It contains dense connective 
tissue, numerous veins, spiral arteries, lymphatic vessels and nerves [3].  
1.1.2 Oogenesis 
During embryonic development, primordial germ cells migrate to the coelomic epithelium of 
the gonadal ridges at the beginning of week 4 of gestation. The stage of gestation is calculated as the 
time since the 1st day of the woman’s last menstrual period [3, 4]. Sexual differentiation occurs in 
weeks 6 and 7 of gestation [5]. The primordial germ cells proliferate and develop into oogonia 
between weeks 7 and 9 [6]. By the twentieth week of embryonic life, oogonia enter meiotic prophase 
and become oocytes. All germ cells then undergo meiosis in response to factors produced by the 
rete ovarii which are small masses of blind tubules or solid cords in the medulla of the mammalian 
ovary near the hilus which are homologous with the rete testis in the male [7]. Most of the oocytes 
are arrested at the diplotene stage of meiotic prophase I (32 μm in diameter) and are referred to as 
primary oocytes in primordial follicles [8]. There are many factors regulating development and 
differentiation of human germ cells in the fetal ovary. Immature germ cells express placental/germ-
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like cell alkaline phosphatises (PLAP) and pluripotency cells which govern by OCT3/4 
(Octamer3/4, a homeodomain transcription factor) expression. The gradual shift from oogonia and 
early oocytes to germ cells and formation of primordial follicles is accompanied with a loss of PLAP 
expression and activation of OCT3/4. These findings revealed that germ cells undergoing 
folliculogenesis were no longer proliferate. Also, expression of c-KIT, β-catenin, and E-cadherin in 
germ cells at all stages of development demonstrates a putative role for these factors for germ cell 
survival and maturation [9]. 
1.1.3 The ovarian reserve 
Three onset of follicle atresia occur in human fetal ovaries. They are comprise of: 1) oogonia 
undergoing mitosis; 2) oocytes largely at the pachnytene stage (Z cells); and, 3) oocytes at diplotene 
stage. At 2 months post-conception, the total number of germ cells is approximately 600,000 
reaching a maximum of 6,800,000 at the 5th month. The population then decreases to about 
1,000,000 at birth. By the 7th year only about 300,000 oocytes persist [7]. The total number of 
follicles per ovary is obtained by estimating follicular density which is the number of structure per 
unit volume multiplied by the ovarian volume [10]. It was recently accepted that the primordial 
follicular density rapidly increases to approximately to 8,000/mm3 at about 5 months of prenatal life 
and subsequently decreases to about 1,400/mm3 8 months after birth [11]. The ultimate number of 
follicles is determined by the balance of oogenia proliferation, germ cell loss and productive 
interaction of diplotene oocytes and somatic cells. All oogonia that are not surrounded by somatic 
cells are expelled from the ovary [7]. The resting follicle pool forms an ovarian reserve from which 
follicles will be recruited for further maturation throughout reproductive life [12]. The ovarian 
reserve is uniquely established during the last phase of the ovarian organogenesis (definitive 
histogenesis) [13]. It is composed of three type of follicles: 1) primordial follicles (~35 μm in 
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diameter) defined as a primary oocyte surrounded by flattened (squamous) granulosa cells; 2) 
‘transitionary’ or  intermediary follicles (~38 μm in diameter) in which the  primary oocyte is 
surrounded by a single layer of both squamous and cubidal granulosa cells; and, 3) primary follicles 
(~46 μm in diameter) characterized by a primary oocyte and a single layer of cubidal granulosa cells 
surrounded by a basement membrane [14]. Most of the follicles in the ovarian reserve are primordial 
and intermediary follicles [15]. Data from a recent study have confirmed that a non-renewing 
ovarian reserve is set in the ovaries at birth and no germline stem cells or neo-oogenesis is present in 
the adult human ovary [16]. However, Jonson et al. (2005) suggested that oocytes might be formed in 
the adult mouse ovary [17]. Putatively oocyte producing germ cells were identified in bone marrow 
and peripheral blood of adult female mice [18, 19]. Later, Bukovsky et al. (2007) reported the 
formation of germ cells in adult human ovaries. By differentiation of primitive granulosa and germ 
cells may occur from the bipotent mesenchymal cell precursors of the tunica albuginea in adult 
human ovaries [20]. Their work has challenged a central tenet of reproductive biology that there 
cannot be an increase in the number of primary oocytes after the ovary is fully mature. 
1.1.4 Initiation of follicular growth 
The mechanisms involved in the initiation of follicular growth are unknown; however, once 
a follicle begins to grow, growth will be continuous until the follicle meets one of two fates: 
ovulation or atresia [21]. Follicle growth commences with 'transition' from the primordial to primary 
follicle stage which is an extremely slow process [22]. There is evidence that the transition stage is 
gonadotropin-independent and is regulated by intra-ovarian factors [23]. 
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Figure 1.1: Classification of follicles in the human ovary (From Gougeon, 1996) 
 
Haematopoietic stem cells, vascular structure, the autonomic nervous system, pre-granulosa 
cells, and the oocyte are known to be originators of the growth stimulating factors of primordial 
follicles [24]. Numerus factors have been implicated in initiating follicular growth. They include 
members of the transforming growth factor β super family (TGF-β), i.e., bone morphogenetic 
protein 15 (BMP-15) and growth differentiation factor 9 (GDF-9), oncogenes (i.e., c-myc and erb-A, 
C-kit), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), fibroblast growth 
factor-7 (FGF-7) and neurotrophins 3 and 4 [25]. Conversely, Anti-Müllerian hormone, 
somatostatin, and activin A from the TGF- β family have been shown to be inhibitors of early 
follicular growth [26]. 
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1.1.5 Pre-antral growth phase 
Follicular growth is characterized by the increasing size of the oocyte and by proliferation of 
granulosa cells (GC) [27]. In the growing follicle, GC proliferation results in an oocyte embedded in 
several layers of cuboidal GC [28]. Meanwhile, mucopolysaccharides are secreted by the granulosa 
cells and condense around the oocyte to form a layer called the zona pellucida that is composed of 
three glycoproteins (ZP1, ZP2, and ZP3) [29]. At this stage, the follicle is termed a secondary follicle 
[28]. Granulosa-oocyte communication is essential for normal oocyte maturation. and gap junction 
proteins (connexins) are expressed at the oocyte granulosa cell junction as the primary follicle 
develops into a secondary follicle [30, 31]. Amino acids, glucose metabolites, and nucleotides are 
transferred to the growing oocyte via gap junctions and the oocyte signals the surrounding GC to 
support their proliferation and differentiation [32]. Similar connections also exist between adjacent 
granulosa cells, indicating that follicle cells can communicate throughout development [4]. The 
secondary follicle with a diameter of ≤ 120 μm migrates into the ovarian medulla [3]. When the 
follicle reaches the secondary stage, granulosa cells express follicle stimulating hormone (FSH), 
estrogen and androgen receptors [7]. As the secondary follicle enlarges, the theca interna and externa 
layers form from the stromal cells and can be recognized as individual cells on the basement 
membrane [13, 33]. The secondary follicle becomes preantral once the theca interna cells become 
epitheloid (fibroblast-like precursor cells) and acquire organelle characteristics of a steroid secreting 
cell. Preantral follicles are categorized as Class 1 follicles [14]. The theca externa is highly 
vascularised, therefore the secondary follicle is directly exposed to factors circulating in the blood 
stream that are necessary for further development [28]. It takes approximately 3 months for primary 
follicles to develop into Class 1 or early-antral follicles [8]. 
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1.1.6 Antral growth phase 
As follicle growth continues, Class 1 (pre-antral, 0.1-0.2mm) follicles develop into Class 2 
follicles (early-antral, 0.2-0.4 mm) or tertiary follicles [4]. Follicles enter into Class 1 during the early 
luteal phase, 25 days later (late follicular phase of the following cycle) they develop to the tertiary 
follicle stage [4]. Over this period, small fluid-filled cavities, or lacunae, form between the GC which 
eventually aggregate and develop into a single cavity called an antrum. Simultaneously, the GC 
immediately surrounding the oocyte form the cumulus oophorus [28]. Two types of granulosa cells 
are classically described beyond this stage: those which surround the oocyte are cumulus cells (CC) 
and those which surround the antrum are termed mural granulosa cells (MGC). Structural and 
functional differences between CC and MGC have been documented. Cell replication is higher in 
CC compared with MGC, they have different responses to FSH, and CC secrete about six-fold 
higher levels of progesterone than MGC [34]. 
 Approximately 20 days later (during late luteal phase) follicles convert into Class 3 (0.4 - 0.9 
mm), and after 15 days (the late follicular phase of the subsequent cycle) pass into Class 4 (0.9 - 2 
mm) [4]. Class 3 and 4 follicles respectively consist of 7.5 x 104 and 3.7 x 105 granulosa cells [14, 15]. 
Approximately 10 days later, in the late luteal phase, follicles enter into Class 5 (2 - 5mm) and consist 
of 1.9 x 106 granulosa cells. These are referred as ‘selectable follicles’ [15]. The conversion of a Class 
1 pre-antral follicle (0.12 - 0.2 mm in diameter) into a Class 5 follicle (2 - 5 mm in diameter) has been 
termed ‘the tonic growth phase’ and occurs over the course of approximately 2 months in humans 
[8]. Oocyte growth is parallel to early follicular growth and the diameter of the oocyte rapidly 
increases from approximately 30 µm in primary follicle to 100 µm in early antral follicle. Thereafter, 
oocyte grows more slowly and ultimately reaches approximately 140 µm in the preovulatory follicle. 
It is suggested that the kit ligand system (C-Kit) induces the oocyte growth at the time of initiation 
of follicular growth [35]. 
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The follicular fluid provides the avascular GC and oocyte with a characteristic endocrine 
microenvironment. It is comprised of free and protein-bound sex-steroid hormones, plasma and 
locally derived proteins, proteoglycans, and electrolytes [36]. It is well established that gonadotropins 
are required for antral follicular development; however, their role remains unclear in the 
differentiation of preantral follicles. Basal levels of gonadotropins are necessary to sustain growth 
and development of the follicle from approximately 2 mm diameter to Class 5. Follicles become 
dependent on cyclic changes of gonadotropins when they reach Class 5 and they remain dependent 
on them until they ovulate at the end of Class 8 stage [14, 15]. According to the “two-cell two-
gonadotropin model” each gonadotropin acts as a specific individual on a separate set of ovarian 
follicle cell, FSH on GC and luteinizing hormone (LH) on theca cells [37]. LH stimulates ovarian 
theca cells to produce androgens, mainly androstendione, that are transferred to GC where they 
aromatized to estrogens (E2) which are released into the follicular fluid, the intrafollicular space or 
the systemic circulation [15, 38]. FSH facilitates in the conversion of androgens to estrogens by 
stimulating the GC aromatase enzyme system, and also induces follicle antrum formation [13, 38]. 
1.1.7 Recruitment 
Follicle development from Class 5 to Class 8 takes approximately 21 days and is termed the 
‘exponential growth phase’ [39]. In humans, this phase includes 3 predominant events: 1) 
recruitment; 2) selection; and, 3) ovulation. During the exponential growth phase, a small group of 
early antral follicles begin to grow rapidly in the late-luteal phase. This is known as recruitment. 
Recruitment is followed by selection of a dominant follicle (DF) in the mid-follicular phase of the 
next cycle. The DF is selected for preferential growth and ovulation [14]. Throughout the life history 
of ovarian follicles, two distinct events are associated with recruitment. MacGee et al. (2000) 
considered these to be: 1) initial recruitment, and 2) cyclical recruitment [12]. 
During initial recruitment, some primordial follicles are stimulated by endocrine and 
paracrine factors to initiate growth whereas others remain quiescent. Initial recruitment begins after 
follicle formation and is continuous throughout life. The oocyte has started to grow, but full 
development will not be completed during initial recruitment. After initial recruitment, oocytes 
remain arrested in the prophase stage of meiosis. Follicles not initially recruited will remain dormant. 
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  Figure 1.2: Initial and cyclic recruitment (McGee, E. A. et al. Endocr Rev 2000). 
 
Cyclic recruitment begins after puberty due to increasing circulating levels of FSH. Three to 
11 antral follicles of diameters from 2 to 5 mm are recruited from the ovarian follicle pool in each 
cycle for further growth [40]. Throughout cyclic recruitment, a limited number of follicles survive 
atresia and the oocytes recommence meiosis [12]. To avoid confusion, we will consider the term 
recruitment to mean “cyclic recruitment” in the rest of this text.  
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The process of follicle recruitment occurs as gonadotropin secretion rises following 
regression of the corpus luteum. At this time in the late-luteal phase, early antral follicles enter into 
the wave of developing follicles from which the preovulatory follicle will emerge. Follicle stimulating 
hormone (FSH) appears to impart a survival action on antral follicles. Luteal regression results in 
decreased progesterone, estradiol and inhibin-A allowing for an increase in FSH. Indeed, FSH levels 
rise around 12 days after the preceding mid-cycle LH surge slightly above (10% to 30 %) the 
‘threshold’ needed rescuing a cohort of small antral follicles from atresia [37, 41, 42]. The duration 
of FSH rise is limited due to a negative feedback of E2 and secretion of inhibin B by antral follicles 
and therefore the concept of the “FSH window” has been proposed [43, 44]. The number of 
follicles in the recruited cohort might be determined by the duration of elevated levels of FSH above 
threshold (window concept) rather than its magnitude [43, 45]. Recently, an important role for β 
anti-mullerian hormone (AMH) in the regulation of FSH sensitivity in the ovary during recruitment 
has been identified in humans [46]. Expression of AMH in women first occurs in GC of primary 
follicles but higher levels of expression are observed in granulosa cells of secondary follicles, 
preantral and small antral follicles ≤ 4 mm in diameter [47]. Anti-mullerian hormone ceases in 
follicles 8 mm in diameter and larger. It is speculated that AMH inhibits follicular recruitment in 
humans. The physiology of AMH inhibition may be similar to that observed in rodents [43]. 
Responses to increasing FSH are also modulated by nonsteroidal products of GC and/or theca 
interna cells such as: 1) the insulin-like growth factors (IGF); 2) epidermal growth factors (EGF); 3) 
fibroblast growth factors (FGF); and, 4) transforming growth factors (TGF); 5) inhibin, and others 
[48-51]. 
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1.1.8 Selection   
Follicle selection is the process wherein one follicle from a wave of growing follicles 
becomes physiologically selected for preferential growth, attains physiological dominance and 
continues development to ovulation [52]. Our understanding of folliculogenesis has recently been 
elucidated by findings that women exhibit two to three follicular waves per ovarian cycle [53]. 
Therefore, selection occurs 2 to 3 times during ovarian cycles. Only the wave that initiates 
development during the late luteal phase produces a pre-ovulatory sized follicle that subsequently 
ovulates [53, 54]. Estimates of follicle diameter at selection time differ. Chikazawa et al. (1986) 
examined ovaries obtained from women by surgery during the follicular and late luteal phases. They 
were sliced serially and then the stained slices were examined to assess the sizes, numbers and 
physiological status of atretic and nonatretic follicles. It was observed that estrogen secretion 
increased proportionally to the growth of DF equal or greater than 8 mm in diameter. A DF seems 
to be selected from 2 to 3 competing follicles with diameters of approximately 5 mm during the late 
luteal phase [55]. Gougeon (1989) believes that follicles are selected between 5.5 and 8.2 mm in 
diameter (Class 6) based on a higher granulosa cell mitotic index in the largest healthy follicle 
compared with other follicles of the cohort. This auther used the ovaries of women undergoing 
laparotomy for various gynecological disorders not directly related to ovarian disease [14, 49]. 
Macklon and Fauser (1999) Pache et al. (1990) observed the first appearance of the DF at mean size 
9.9 ± 3.0 mm using transvaginal ultrasound examinations [56, 57]. Later, Van Dessel et al. (1996) 
obtained fluid from ovarian follicles in vivo during surgery from regularly cycling women with proven 
fertility and showed that intrafollicular estradiol concentrations rose only in follicles greater than 
9 mm in diameter. A significant increase in aromatase enzyme activity occurs only in the selected DF 
[58]. Finally, Baerwald et al. (2003) demonstrated that follicle selection was manifest at approximately 
10 mm in diameter based on transvaginal ultrasonographic evaluations of natural menstrual cycles 
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[53, 54]. The overall consensus seems to be that the selection process does not occur before follicles 
reach 8 mm in diameter [48].  
Selected follicles enter Class 5 (4.7 ± 0.2 mm in diameter) during the late luteal phase and 5 
days later enter Class 6 (5.5 to 8.2 mm in diameter) in the early to late mid-follicular phase. 
Dominant follicles can be distinguished from their cohorts by their larger size (6-10 mm), higher 
mitotic index, detectable amounts of FSH and a considerable amount of estrogen in the follicular 
fluid [59, 60]. Five days later, the DF reaches 10 to 16 mm in diameter and then ovulates in another 
5 days [4]. During selection, the follicle gradually enlarges from 7 mm (2 to 5x106 GC) during the 
early follicular phase to 9 mm (50 to 100x106 GC) in the late follicular phase [15]. The mechanism of 
selection of a DF is a critical, but a poorly understood. Identification of the timing of preovulatory 
selection is a key component in understanding natural and peri-menopausal ovarian function, 
ovarian suppression for contraception, and improvement of ovarian stimulation protocols. 
 Ireland et al. (1983) showed that the binding of labelled hCG was not different between 
estrogen active and estrogen inactive follicles on days 3 or 5 of the estrous cycles in cattle 
(presumably DF and SF) [186]. Later, Evans et al. (1997) reported that the DF has been selected by 
day 2 of the first follicular wave in cattle based on their diameters and estradiol secretion in vitro. 
There was also a lack of mRNA for LH receptor in granulosa cells on days 2 or 3 of the follicular 
wave  [187]. This result was in agreement with the finding that the acquisition of LH receptor on 
granulosa cells does not play a role in selecting the dominant follicle. 
There is presumptive evidence that biochemical changes occur in selected follicles before it 
is obviously larger than other follicles of the wave [61, 62]. The recruitment process is preceded by 
an FSH surge and there are two significant responses of the GC to FSH: 1) the induction of 
aromatase; and 2) the induction of LH receptors. The aromatase activity of GC is required for 
androgen conversion to estradiol. The increasing levels of circulating estradiol and inhibin secreted 
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from GC of DF contribute to FSH’s decline to basal levels through a negative feedback mechanism 
which is necessary to sustain the development of less mature follicles. In humans, there is a 
simultaneous increase of estradiol in the follicular-fluid of DF and systemic circulation [51]. High 
concentrations of estradiol in the follicular fluid are hallmark of dominant preovulatory follicles [61]. 
In addition, DF are characterized by decreased levels of inhibitory low molecular weight IGF-
binding proteins (IGF-2,-4, and-5) [63]. The resultant increase in bioactive (free) IGF allows the DF 
to synergize with FSH enhancing follicular growth and estradiol production [64, 65]. The induction 
of LH receptors is responsible for further maturation of the DF during the mid-to-late follicular 
phase when LH concentrations begin to increase [66]. Occupancy of FSH and LH receptors result 
in a similar cellular responses since both receptors are coupled to a cAMP signalling system [67]. 
Therefore, the GC of DF respond similarly to both FSH and LH; however, at non-saturating levels 
of both gonadotropins the responses are additive [68]. It is speculated that LH is able to substitute 
for FSH in the FSH-stimulated DF and provide the maturing follicle with an additional source of 
gonadotropic support [69]. In an extensive series of studies, early DF has been shown to contain 
higher levels of mRNA for LH receptors in both theca and GC than the SF of the same cohort. 
Levels of mRNA for the FSH receptors in granulosa cells were similar in dominant and SF. likewise, 
mRNA levels for 17α-hydroxylase and aromatase which convert progestins to androgens in theca 
cells and androgen to estrogen in GC, respectively, are higher in newly selected DF than SF [61]. 
Another significant aspect of the DF compared to SF is the development of an extensive vascular 
plexus in the thecal layer which creates a blood supply providing preferential delivery of 
gonadotropin to the newly formed LH receptors [70, 71]. If a gonadotropin surge occurs the mature 
follicle will ovulate and in the absence of gonadotropin surge it has the same fate as the SF, atresia 
[69]. 
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1.1.9 Atresia 
During puberty, the ovarian reserve contains only 300,000 follicles, from which 400-500 will 
ovulate in the course of a normal reproductive life span [7]. Atresia literally means as “without 
perforation” [72]. The mechanisms engaged in regulating and controlling atresia are not fully 
elucidated. Since 1990, there have been extensive studies designed to determine the precise temporal 
and molecular processes. Our current understanding is that deprivation of survival agents and 
presence of “death ligands” are the first steps of atresia [72]. Pituitary hormones (FSH, LH, and 
GH), estrogen and locally produced growth factors promote follicular growth and suppress the 
apoptosis process [73, 74]. A stimulus for apoptosis is the absence of these factors [75]. Recent 
studies reveal that atresia is mainly cause by apoptosis of granulosa cells [76]. Potential triggers for 
apoptosis in the granulosa cells are death ligands and receptors, intracellular pro-and anti-apoptotic 
molecule, cytokines, and growth factors. Death receptors include a subfamily of the tumor necrosis 
factor receptor superfamily (TNFRsf) which contains a cytoplasmic death domain necessary for the 
activation of apoptosis [77]. TNF-α has a dual action which induces both cell death and cell 
proliferation through different receptors (TNFR-1 and TNFR-2 are apoptotic and anti-apoptotic 
respectively) [78]. At the beginning of atresia, the TNFR-1 receptor is trimerized then binds to death 
ligands which include the tumour necrosis factor-α (TNF-α), TNF-α receptors (TNFRs), Fas ligand 
(FasL), Fas (CD95, APO-1, TNFRsf6), and TNF-α-related apoptosis-inducing ligand (TRAIL), 
TRAIL receptors [79, 80]. The extracellular DD (death domain) of the cell death receptors have an 
intracellular DD by which it binds with the DD of the adaptor protein (Fas-associated death 
domain: FAD) [77, 78]. Thereafter, an initiator caspase (procaspase-8; FLIC) attaches to FADD 
through the death effectors domain, resulting in a death-inducing signalling complex, fragmentated 
DNA, and finally apoptosis [79]. Recently, it has been documented that the FasL protein is located 
in the cytoplasm of granulosa cells in healthy follicles. When GC apoptosis commences, Fas moves 
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from the cytoplasm to the cell membrane and initiates the process [80]. In some species, Fas is 
observed in the oocytes and also in cumulus cells suggesting a role in oocyte death [81]. 
1.1.10 Ovulation 
Ovulation is a complex, inflammatory-like process wherein the fertilizable cumulus oocyte 
complex is expelled from a mature preovulatory follicle. It is preceded by a preovulatory rise in LH 
[82, 83]. In 1932, the first major report on ovulation was written by Carl Hartman. He considered 
ovulation as the “sine qua non” of the reproductive process and pointed out that the cyclic sexual 
phenomena are separated into those occurring before and after ovulation [84]. Three years later, 
Adsell argued that follicle rupture as a consequence of increasing intrafollicular pressure, promoted 
by the contraction of smooth muscle tissue in the ovarian stroma [82]. This premise was believed to 
be true until 1962. Since then it has been shown that ovulation occurs due to a series of biochemical, 
and morphological changes induced by the mid-cycle gonadotropin surge. 
Prior to ovulation, there are five distinctive layers at the apex of a Grafian follicle [83]. The 
outermost layer is the surface epithelium. The second layer is the tunica albuginea which is the most 
durable part and consists of fibroblasts and collagens. The third layer is the theca externa, which is 
the follicle’s own capsule of collagen fibres and connective tissue. The theca interna is the forth layer 
consisting of steroid-secreting cells and vascular tissues. It is separated from the innermost layer by a 
basal lamina. The innermost layer is the stratum granulosum [3]. Around the time of ovulation, the 
apical follicle wall becomes thinner and the deep internal wall becomes thicker. Subsequently, a 
conical stigma forms on the surface of the ovary as the follicle protrudes from it [85]. The stigma is 
the site of follicular rupture and release of the cumulus-oocyte complex (COC). The COC is the 
oocyte surrounded by the cumulus oophours cells. Ovulation starts with gentle expulsion of the 
17 
 
oocyte and antral fluid when intrafollicular hydrostatic pressure of about 20 mm Hg finally 
overcomes the resistance of the very thin apical tissue layers [85]. 
It is documented that LH induces marked increases in ovarian blood flow prior to ovulation 
[86]. The high concentration of intrafollicular esteradiol and androstenedione decreases with the 
ovulatory LH surge due to an LH induced inhibition of the thecal P450-17α/lyase complex. At the 
same time, a marked increase in progesterone and 17α-OH progesterone occurs from GC which in 
turn terminates the LH surge by negative feedback on the hypothalamo-pituitary-ovarian axis [15, 
87]. Progesterone is important in ovulation; however, its proteolytic function has not been 
determined. Since progesterone is the main indicator representative of luteal function, it seems that 
luteinisation of follicular tissue begins before follicular rupture [83].  
The lutinzation process that commences before follicular rupture consists of 2 distinct but 
parallel events: 1) the transformation of the theca interna and stratum granulosum of the follicle wall 
into steroidogenically active lutein tissue, and 2) the disruption of the basement membrane between 
the GC and the thecal layer and vascular migration into the luteinizing granulosa layer [91]. The 
corpus luteum synthesizes substances essential for initiation and maintenance of pregnancy. Besides 
progesterone, the corpus luteum also produces estrogen, relaxin, and inhibin-related peptins [53]. If 
fertilization does not occur, the corpus luteum regression begins after approximately 7 days. 
Alternatively, if pregnancy occurs, the corpus luteum persists in the ovary until the time of the 
luteal-placental shift. It has been suggested that LH along with two local factors, estrogen and 
PGF2α are responsible for the corpus luteum regression [94]. 
Oocyte Maturation Inhibitor (OMI) restrains oocyte maturation prior to ovulation while 
increased LH level during mid-cycle suppresses its action [88]. The LH threshold must be attained 
and be constant for about 14 to 27 hours to provoke meiosis resumption and development from the 
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diplotene stage to metaphase II. A second meiotic arrest occurs at the time of ovulation and meiosis 
will only be completed after fertilization [84, 87].  
Shortly after the LH surge, attachments between the leukocytes and the endothelial cells 
along the post-capillaric venules are initiated due to gonadotropin-induced gene expression. This is a 
recognized inflammatory event. In addition to the leukocytes driving inflammatory mediators, local 
hydrolytic enzymes play an important role in initiation of the inflammatory cascade during ovulation. 
Different inflammatory agents have been studied in ovulatory tissue. Kinin, a vasodilatory agent, 
formation increases 10-fold during the ovulatory process in the rat ovary. In contrast, ovarian 
histamine and plasminogen activator factor (PAF) decrease at the same time probably due to 
degranulation of mast cells and histamine release. There is also activation of the arachidonate 
cascade [83]. Immediately after the LH surge, the GC and theca interna cells produce plasminogen 
activator (PA) which converts of plasminogen to plasmin in the follicular fluid. Plasmin which acts 
as a proteolytic enzyme catalyzes procollagenase conversion to collagenase. Collagenases break 
down collagen within the follicular apex [85]. Prostaglandins (PG) E and F increase in preovulatory 
follicles. The specific roles of prostanoids in ovulation in not fully understood; however, the PG 
play significant roles in inflammatory reactions [86]. It is not certain whether they serve as 
degradative agents or they are a response to the inflammatory-like changes in the follicle. 
The mid-cycle gonadotropin peak induces the expression of numerous genes in the cumulus 
oocyte complex as well as in the GCs and theca cells [89]. These include prostaglandin synthase-2 
(Ptgs2 or Cox2), genes associated with the cumulus oocyte complex (COC) matrix formation, 
hyaluronin (HA) synthase 2 (Has2), the HA-binding proteins, TNFα-induced orotein-6, and a vast 
number of other genes involved in inflammatory processes [90, 91]. Different events are observed in 
COC during ovulation as a consequence of specific gene expression at the time of ovulation. They 
include: 1) “cumulus cell expansion”; 2) altered interaction of the somatic cells with the germ cell; 
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and, 3) the resumption of meiosis. Cumulus cell expansion is associated with secretion of hyaluronic 
acid and the disruption of gap junctions between the neighbouring cumulus cells [92]. When the 
follicle wall finally ruptures at the apex of stigma the follicular fluid and oocyte evacuate the antral 
cavity. The cumulus oophorus cells remain with the ovulated oocyte and probably assist with the 
capture of the oocyte by the fimbriated end of the oviduct [93]. The duration of follicle evacuation 
appears to be associated with the stigma size and ranges from 6 seconds to 18 min [90].  
1.1.11 Wave theory of folliculogenesis 
Introduction of ultrasonography in the late 1980’s ushered in a new understanding of 
ovarian follicular dynamics. Our understanding of follicular waves was first elucidated in animal 
models (e. g., bovine, equine, ovine). Follicular waves are described as the synchronous growth of a 
group of follicles from which one or more follicles are selected for further preferential growth. The 
majority of bovine estrous cycles are comprised of two or three such waves [95, 96]. In cows, the 
final wave of follicular development is ovulatory, while all preceding waves are anovulatory [97, 98]. 
Animals with 2 waves of follicular development exhibited an inter-ovulatory interval (IOI) of 20 
days. Those with 3 waves exhibited a longer IOI (23 days) which was attributed to a longer luteal 
phase (i.e., longer lifespan of the CL) while the follicular phase remained unchanged [99]. The 
progesterone secreted by the corpus luteum in cows had a suppressive effect on LH and inhibited 
the ovulation of DF in major anovulatory waves which occurred in the luteal phase [100]. 
Ovarian follicular waves with major and minor follicular wave patterns also have been 
documented in the mare [94]. Major waves were defined as the growth of a cohort of follicles 
followed by the selection of a follicle for preferential growth (DF) and the regression of all other 
follicles (SF). Two types of major waves were characterized: primary and secondary. Primary waves 
occurred during diestrus and gave rise to an estrous ovulation. Secondary waves originated during 
estrus or early diestrus and gave rise to a dominant anovulatory follicle, hemorrhagic follicle or a 
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diestrus ovulation. Minor waves were characterized by the failure of any one follicle to become 
dominant [101]. In cows and mares, the emergence of each follicular wave was preceded by an 
increase in the circulating level of FSH [100]. The selection of DF was associated with a decrease in 
FSH level, acquisition of granulosa LH receptors, and rising circulating concentration of estradiol 
[102, 103]. Recent comparative studies in monovular farm animals (cattle, mares) and women have 
indicated similarities of the dynamic of follicular waves [104, 105]. These results have encouraged 
the use of cows and mares as the most relevant experimental models for the study of folliculogenesis 
in women. 
In humans, morphological studies by Block (1952) initially demonstrated 2 periods of 
increased follicular growth during the 'sexual cycle'. The first wave, from which an ovulatory follicle 
developed, occurred early in the cycle under the influence of FSH. The second wave of 
folliculogenesis occurred in the early luteal phase. He reported that follicles that grew > 5 mm within 
the second wave in the mid-late luteal phase were atretic [106]. In 1986, Gougeon provided a 
different understanding of the folliculogenesis based on histological observations in ovaries obtained 
during gynecological surgery in women. He postulated a continuous entry of follicles into the 
growth phase [4]. The idea of continuous follicular recruitment has been termed the “Propitious 
Moment Theory”. According to this theory a single follicle grew by chance during a hormonally-
privileged period of the cycle in women [110]. Accordingly, antral follicles were recruited and grew 
continuously until occurrence of a gonadotropin surge that stimulated ovulation of the mature 
follicle  [111]. A biphasic pattern of reproductively active hormones has been shown during 
endocrine evaluations of the human menstrual cycle. Luteinizing hormone (LH) pulse frequency 
rose in the early luteal phase (~20 pulses per day) and early follicular phase (~20 pulses per day), 
21 
 
compared to the mid-luteal phase (~ 5 pulses per day) [102]. Activin and inhibin were shown to be 
secreted in biphasic patterns during the cycle as well [107]. 
It was generally accepted that a cohort of follicles were recruited to grow in the late luteal 
phase of the menstrual cycle, a single follicle was selected for preferential growth the mid-follicular 
phase. Ovulation occurred at mid-cycle and there was limited follicle development during the luteal 
phase. The dynamic and physiological events of follicular wave development were not fully 
appreciated until the discovery and characterization of human follicular wave dynamics [12, 48, 53, 
98, 108, 109]. 
Recent studies have characterized a wave-like pattern of human ovarian follicular 
development [94]. Non-invasive, high-resolution transvaginal ultrasonographic evaluations have 
shown that each menstrual cycle in women is compromised of two or three major or minor waves 
of follicular development. Major waves were defined as those in which a single follicle was selected 
at 10 mm of diameter to attain further growth and become the DF while the other follicles (SF) 
underwent atresia. In minor waves, the selection of the DF was not manifest. The DF of ovulatory 
major waves ovulated, whereas the anovulatory DF regressed during major waves. The final wave of 
the interovulatory interval (IOI) was an ovulatory major wave, whereas preceding waves were minor 
or major anovulatory waves [53, 112]. The emergence of both major and minor follicular waves was 
preceded by an increase in the circulating level of FSH. Women with two wave cycles exhibited 
shorter cycles than those with three waves of folliculogenesis. Therefore, during the follicular phase, 
the blood level of estradiol increased earlier in women with two versus three follicular waves, which 
attributed to earlier production of E2 by DF cycles. Likewise, preovulatory surges of FSH, LH, and 
E2 occurred earlier in women with two versus three follicular waves [53].  
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1.2 Ultrasonographic imaging of the ovaries 
1.2.1 Overview of ultrasonographic imaging 
 Prior to the introduction of ultrasonography, studies of human ovarian follicles were based 
on autopsy and surgical specimens. The histological studies provided non-dynamic information of 
ovarian physiology at single points in time. They were time-consuming, invasive, and did not allow 
elucidation of ovarian events over time. Ultrasonography profoundly changed our ability to detect 
morphological changes that occur within the reproductive organs without interfering with the 
physiological processes of these organs. Ultrasonographic imaging provided a direct, non-invasive 
and atraumatic tool to observe natural changes in the ovarian follicle dynamics in vivo and has 
become an essential tool for understanding ovarian physiology as well as diagnosis of ovarian disease 
for clinical purposes [95, 113, 114, 115].  
 Transabdominal ultrasound (TA) provides an overview of the pelvic contents. Some early 
comparative studies showed that transvaginal ultrasonography (TV) could effectively replace TA 
examinations for routine ultrasonography of the female pelvis. Increased resolution, less patient 
discomfort, and elimination of the need for patient preparation are potential advantages of TV 
ultrasound over TA approaches [109, 116]. Transvaginal ultrasonography is used to observe ovarian 
follicular maturation and ovulation during menstrual cycles, detect early pregnancy, and assess the 
uterus and ovaries for anomalies such as cysts, tumours, fibroids and endometriomas. In addition, it 
is useful in management of infertility, ovulation induction prior to insemination, oocyte retrieval, and 
management of controlled ovarian hyperstimulation [115, 117]. 
 Ultrasound instruments are comprised of a piezoelectric transducer connected to a console 
that contains the image adjustment controls used by the operator and the viewing screen. The 
transducer sends high frequency acoustic pressure waves into the body, converting electric energy 
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into mechanical energy to generate ultrasonic waves then receives echoes and converting the 
returning acoustic energy into electric energy which may be viewed. Ultrasound is defined as 
acoustic pressure waves that have a frequency (above 20,000 hertz) beyond the human audible range 
(20 and 20,000 hertz). Ultrasonographic imaging is based upon the ability of different tissue 
structures to reflect high frequency sound waves [115]. Acoustic pressure waves are emitted from 
the piezoelectric transducer and transmitted into adjacent tissues. Ultrasound waves can travel 
through liquids, tissues and solids, and are either reflected or scattered by tissues and tissue 
interfaces. The characteristics of the tissue interfaces (changes in tissue density) determine what 
proportion of the sound wave will be reflected or transmitted (ecogenicity). Each tissue has a 
characteristics signature which is reflective of acoustic impedance [118]. 
 The reflected echoes are detected by the transducer, processed and displayed on the 
ultrasound unit screen, in shades of gray extending from black to white. Hyperechoic tissues (dense 
tissues, such as bone) reflect much of the sound waves and appear bright whereas anechoic parts of 
organ (fluid) do not reflect sound waves and appear black in the ultrasound images. The speed of 
sound waves depends upon the characteristics of the medium in which the sound wave is traveling. 
It increases with increasing tissue density. In soft biological tissues, the velocity of ultrasound waves 
is approximately 1540 m/s. In fluid, it is about 1480 m/sec, and in bone it is 3500 m/sec. Most 
ultrasound devices are calibrated for average velocity of sound in soft tissues or water [115, 119]. In 
addition to tissue density and sound waves velocity, the “gain” controls of ultrasound system adjust 
the optimal balance of the grey tones displayed in the images. Echoes returning to the transducer 
from tissues located at large distance from the transducer are weaker than those returning from 
nearby tissues, resulting from sound beam attenuation in the medium. Therefore the intensity of 
viewing screen varies at different depths of tissue. Receiver amplification can be increased by 
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applying the internal gain controls. Thereby, balancing echoes originating from distal reflectors and 
echoes originating close to the transducer [120]. Overall, near and far gains regulate the near field, 
and the far field brightness of the image respectively [119]. 
 The transducer receives reflected sound waves and converts them into electrical energy. 
Then the scan convertor amplifies and stores the images in a binary formatted, analog-to-digital 
conversion. The digital scan converter memory consists of a matrix of elements, or pixels, and is 
typically 480 x 640 pixels in the current generation of ultrasound instruments. The echoes stored or 
written in the memory are displayed on a monitor. An electron beam is directed and displayed as 
scanning and raster lines on a monitor. The image is made up of a number of pixels, varying in grey-
scale value from 0 (black) to 255 (white) [121, 122]. 
 The ultrasonographic appearance of a tissue is referred to echotexture. Echoes can be 
displayed in different modes. A-mode or Amplitude shows echo signal amplitude verses reflection 
distance. It enables accurate transducer-to-tissue distance measurements. M- mode or motion mode 
is generated by sweeping a B-mode trace across the screen while the ultrasound beam is stationary. 
It is mostly applied in echocardiography. In B-mode, or brightness mode, the echo signals are 
converted to intensity-modulated dots on the screen and used in both generating M-mode and two 
dimensional imaging [107, 115].  
 The first step in interpreting ultrasound images is to obtain detailed knowledge of the 
relationship between tissues and echoes, and ability to differentiate between factual and artificial 
responses. Certain shapes and structures of tissues change the direction of sound waves which 
produces artifacts. If sound waves strike an interface that is smooth and wider than the beam and 
parallel to the transducer, a specular reflection will be generated. Non-specular reflections are 
produced when the sound waves strike a rough or narrow interface scattering the sound wave in 
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many directions. Blockage or deviation of the sound waves makes a shadow artifact. When the beam 
passes through a reflector-free structure, the pulse is not attenuated resulting in a column of brighter 
echoes beneath the structure known as an enhancement artifact. Another type of atrifact is termed 
reverberation in which the wave sounds bounce back and forth between two strong interfaces until 
the beam are exhausted by attenuation [115, 121]. However, artifacts can cause misinterpretation of 
normal or pathological structures, therefore knowledge and discrimination of nature and origin of 
the actual and artifactual echoes can decrease misinterpretation.  
1.2.2 Ultrasonographic characteristics of the normal ovary    
 In women, normal ovaries contain follicles and/or corpora lutea throughout the 
reproductive age range. The ovaries are normally observed as almond-shaped organs located lateral 
to the uterus, above and medial to the hypogastric vessels. The size of ovary is related to the phase 
of follicular development and age, but normal healthy ovaries do not usually exceeded 4 x 3 x 2 cm. 
Their size is variable during menstrual cycle. Ovarian size also decreases as menopause approaches 
[123]. In ultrasonographic images, the ovary is visualized as a coarse, low-level echo pattern 
interrupted with anechoic (i.e., dark) areas that represent developing follicles, functional cysts or 
corpora lutea. Ovarian follicles are imaged as circular hypoechoic (i.e., dark) structures surrounded 
by a thin hyperechoic (i.e., brighter) follicle wall [124]. Follicles as small as 2 mm in diameter can be 
detected by ultrasound [125]. A mature preovulatory follicle generally measures 20 to 24 mm in 
diameter [124]. The ovarian vasculature can be easily detected using Color and Power Doppler 
imaging techniques [111]. The ovarian artery is a branch of the uterine artery and passes through the 
infundibulopelvic ligament. As ovulation approaches, vascularization of the theca cell layer increases. 
Therefore, thecal and granulosa cell differentiation produces a subtle double contour inside the 
follicle wall [124]. 
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Ultrasonographically detectable changes associated with impending ovulation include 
cumulus-oophorus expansion 12 to 24 hours before ovulation, thinning of the apex of the follicle 
wall approximately 3 hours before ovulation and the follicle wall becoming less echoic (darker), 
more loosely organized and better vascularized [90, 126]. The follicle wall becomes irregular in shape 
[109]. Fifteen to 20 minutes before ovulation, a stigma forms at the follicular apex followed by the 
rupture of the wall and the rapid release of 50% of follicular fluid within the first 15 seconds. 
Complete evacuation of follicular fluid occurs within 6 to 18 seconds [7, 90]. 
 The corpus luteum (CL) forms immediately after the collapse of the follicle and extrusion of 
the egg and follicular fluid. Ultrasound characteristics of the corpus luteum are highly variable and 
involve significant macroscopic changes. The CL usually appears as a hypoechoic structure with an 
irregular wall and may contain some internal echoes corresponding to haemorrhages. Four to eight 
days after ovulation, it appears as an echoic area approximately 15 mm in diameter. The CL tissue 
area and vascularity reach maximal levels 6-7 days after ovulation. Haemorrhage within the corpus 
lutem has been observed in 60% of women and appears as a solid or complex mass on 
ultrasonography. There is no correlation between the CL size and structure and progesterone level 
during luteal phase [127]. Some investigators have classified the CL into four groups by assessment 
the relative hypoechogenicity or hyperechogenicity and the maximum thickness of the wall [128]. 
The luteal regression occurs 6-7 days after ovulation. The CL degenerates into an amorphous hyaline 
mass held together by strands of connective tissue referred to as the corpus albicans (CA). The end 
product CA is a hyperechoic mass of scar tissue that eventually regresses completely over the course 
of the next few menstrual cycles [129]. 
 Failure of ovulation may is rise to 1 of 3 distinct types ovarian structures: 1) anovulatory 
follicular cysts; 2) luteinized unruptured follicles (LUF); and, 3) hemorrhagic anovulatory follicles 
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(HAF) [128]. Anovulatory follicles are characterized by a thin highly echoic (i.e., bright), clearly 
demarcated follicular wall of uniform thickness with an echotexture that is distinctive of a cohesive 
tissue layer. The increased gray-scale values of the follicular wall may be associated with decreased 
vascularity. Echoic structures protruding into the follicular antrum and floating freely in the 
follicular fluid may be observed [128]. The COC and stigma are not usually visible [126]. These types 
of follicles generally exceed normal ovulatory diameter (i.e., >25 mm) remain static for one to 
several days and then regress without apparent luteinization [130]. Luteinized unruptured follicles 
(LUF) attain ovulatory diameter with thick follicular walls and hazy indistinct borders at the 
antrum/wall interfaces. The walls have similar echotexture to luteinized tissue. There is occasionally 
visual evidence of occyte is trapped within the LUF. Luteinized unruptured follicles typically regress 
after a time course similar to the CL. Hemorrhagic anovulatory follicles are identified by 
haemorrhage into the antral cavity and the formation of fibrin network within the antrum [130]. All 
of these types of ovulation failure have been reported in healthy women and are associated with 
infertility [125]. 
1.2.3 Computer-assisted image analysis   
 The human eye can perceive smooth transitions in shades of gray, but can only distinguish 
among 18 to 20 shades of gray, therefore, most of the gray-scale information within an ultrasound 
image is inaccessible to the human eye [124]. Recently, new techniques have been developed to 
evaluate ultrasound image attributes. Computer-assisted image analysis techniques have been used to 
quantify echotextural characteristics within the image by using a series of processing steps and 
complex computer algorithms [131]. The validation of this technique has been verified through 
correlation of ultrasound image attributes with histological attributes in animal models. It is 
important to avoid placing sampling lines on image artifacts (i.e., enhanced through-transmission, 
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shadowing, specular echoes, refraction, and beam width artifacts). These artifacts may falsely 
increase or decrease image attribute values resulting in inaccurate interpretation of the physiologic 
status of the ovarian structure. For multiple examinations of images of the same structure over time, 
consistency in equipment (scanner and transducer) and machine settings (near field, far field, and 
overall gain) is essential [132-135]. 
 Three image attributes are quantified during ultrasound image analysis of ovarian follicles. 
They are: 1) numerical pixel value (NPV) defined as the mean pixel gray-scale value of the sampled 
pixels, which is an average value of all pixels (black=0, white=255) within the area of interest; 2) 
pixel heterogeneity (PH) defined as the degree of deviation from the mean (standard deviation) of 
pixels values of the sampled area; and, 3) the region selected volume (RSV) defined as mean gray-
scale values within the selected region in 2 dimensions, length and width (GSV/mm2). Application 
of spot metering, linear and time-series analyses, and regional surface analyses allow us to extract 
numerical data and enhance our visual interpretation of the ultrasonographic image [131, 136]. 
1.2.4 Spot metering   
 The simplest quantitative method for analysing ultrasound images is to select one or more 
small circular areas of interest. Then the computer software determines the precise gray-scale value 
of the pixels within the sample area and provides image attributes such as NPV, PH. This technique 
is applied to compare different areas within the same follicle or the same area of the follicle at 
different times. For instance, different portions of the follicle wall or corpus luteum may be analyzed 
to evaluate characteristics associated with follicular growth and regression, impending ovulation, 
atresia and luteal development and regression [111, 131]. Results are generated in the form of 
numerical values which are representative of morphological and histological characteristics of the 
follicle tissue at different stages of development. 
  
29 
 
 
1       2 
3 4
5
Figure 1.3: Computer-assisted image analysis of the ovarian follicle ultrasound. Spot analysis of the 
antrum was performed to measure the mean numerical pixel values and pixel heterogeneity by 
placing small circles at four different locations (1, 2, 3, 4) over the follicle antrum. Line analysis of 
the follicle wall was performed by drawing a line at 4 o’clock position (5).  
  
1.2.5 Linear and time series analysis 
 In the linear analysis approach, a computer-generated line (one or more pixels wide) is drawn 
across a specific region of the follicle or luteal structure of biological interest. The intensity of each 
pixel within the line are displayed on a two dimensional graph which compares distance versus pixel 
value. This technique is used to evaluate changes in the wall of a single follicle or different follicles 
over time. The computer software determines the precise gray-scale value of the pixels along the line 
and provides image attributes such as NPV, PH, and RSV. To provide information of changes over 
time, many lines at different locations of the follicle wall and antrum can be concatenated to obtain a 
single image. This is termed the time series technique. In the next step, a shading algorithm is 
applied to show detailed analysis of the surface contours of the follicular walls and fluid. The 
resultant three-dimensional graph displays follicle diameter, pixel intensity and time. By using time 
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series analyses in combination with other methods, the follicular wall and antrum can be assessed 
visually as the follicle progresses through different stages of growth and regression [111, 131]. 
1.2.6 Region analysis 
 Region analysis is the most promising technique for visual evaluation of the physiological 
status of a follicle. This technique involves overlaying a pixel-by-pixel mesh onto a selected region of 
the follicle to produce a three-dimensional image. The graph compares the follicle diameter (length 
and width), and pixel intensity. A computer-generated skin can be placed over the mesh framework 
to provide a topographical image. Shading algorithms and color can be added to the image to 
enhance visual perception and allow comparison of different portions within images of different 
follicles or images of the same follicle over time. Region analysis may develop into a clinical tool 
useful tool to instant assessment of ultrasound image attributes associated with the health and 
viability of the follicle. By applying the region analysis technique, DF can be inspected for 
echotextural changes indicative of physiological status. Therefore, biologically important times can 
be identified and employed to evaluate the effects of infertility therapies or contraceptive regimens 
to increase their effectiveness [111, 131]. 
 A B C 
Figure 1.4: Regional analysis of a preovulatory follicle. An image of the follicle is shown with follicle 
wall identified by the yellow line (A). Computer generated “skin” stretched over the selected area of 
the follicle (B). Height-shaded color algorithm added to enhance visual appreciation (C).  
1.3 Ovarian follicular development during oral contraceptive use 
1.3.1 Characteristics of oral contraceptives 
The development of oral contraception in 1960 radically changed the contraceptive choices 
for women. Enovid™, which contained synthetic estrogen (150 μg mestranol) and synthetic 
progestin (9.85 mg norethynodrel) was initially introduced as a menstrual regulator [128, 137]. In 
1960, the Food and Drug Administration approved Enovid™ as an oral contraceptive. Today, OC 
(oral contraceptives) are the most commonly used, reversible type of contraceptive in the world 
[129, 138]. Combined OC contain an orally-active progestin and estrogen. The currently used OC 
combine ≤35 μg  Ethinyl estradiol (EE) with a synthetic progestin [139]. Supra-physiologic levels of 
estrogen and progestin provide negative feedback on the hypothalamo-pituitary axis [140]. 
Reductions in endogenous GnRH, FSH and LH suppress ovarian follicular development, preventing 
ovulation and subsequent conception. The progestin component of OC directly affects ovarian 
function with inhibition of the LH surge and subsequent ovulation [141]. In addition, progestin 
decreases the permeability of the cervical mucus and endometrial receptivity for embryo 
implantation, and decreases tubal and uterine motility causing a delay in gamete transport [142]. The 
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exact mechanism of action of the estrogen component has not yet known. In primates, estrogens 
have been shown to inhibit the growth of pre-antral and medium-sized antral follicles through 
inhibition of FSH secretion [143, 144]. Estrogen is also required to provide socially acceptable 
bleeding patterns in women during regular OC use [129]. The most recent OC formulations contain 
EE doses as low as 15 μg. In addition, use of 3rd and 4th generation progestins (i.e., levonorgestrel, 
deosgestrel, gestodene, and norgestimate) has resulted in more effective OC regimens [129]. 
Oral contraceptives are generally categorized into monophasic and triphasic formulations, 
based on their hormonal content. Monophasic OC contain the same amount of EE and progestin 
hormones in each pill, while triphasic OC have varying amounts of either EE, progestin, or both 
throughout the cycle [139]. Triphasic OC were designed to mimic the rising and falling of estrogen 
and progesterone during the natural cycle [146]. Conventional OC administration consists of a 28 
day cycle comprised of 21 daily active pills followed by a 7-day hormone free interval (HFI) to 
mimic the physiological event of natural menstrual cyclicity [147]. Currently, continuous OC dosing 
scheme is used in which women take OC continuously for months at a time and discontinue for a 
withdrawal bleed only a few times a year [148]. Progestin-only OC are also used as contraceptives in 
special cases such as during lactation; however, they are less efficient in preventing pregnancy than 
to combine OC [149]. 
In most studies, the efficacy rate of OC is reported as failure rate during 1 year of use. The 
expected efficacy rate is < 2%, but the actual rate is reportedly < 5% [150, 151]. The Pearl Index is 
the standard way for reporting the effectiveness of a birth control method and is defined as the 
number of pregnancies per 100 women-years of treatment [141, 144, 150, 152]. Ovarian follicular 
development is not completely inhibited in OC users, and the degree of ovarian activity depends on 
the type and dose of steroid in the OC, the administration regimen, and user compliance [152].  
33 
 
Adverse reactions to OC are considered to be estrogen, progesterone, or androgen-related 
effects. They include nausea, fluid retention, headaches, breast tenderness, breakthrough bleeding, 
spotting, hypertension, fatigue, depression, oily hair and skin, hirsutism, increased appetite, weight 
gain, and acne [153, 154]. A small increase in risk of breast cancer has reported. Incidences of 
myocardial infarction and cerebrovascular disease are slightly higher in OC users who smoke 
compare to the normal population [155, 156]. Oral contraceptives also offer many non-
contraceptive benefits. These include improvement of dysmenorrhoea, increasing bone mineral 
density, prevention of iron deficiency anaemia, lower risk of ovarian and breast cyst formation, and 
decrease the risk of endometrial, ovarian, and colorectal cancers [146, 157]. 
1.3.2 Follicular development during oral contraceptive use  
Follicular development to ≥ 10 mm in diameter and “escape” ovulation have been observed 
in OC users [158, 159]. During natural menstrual cycles DF become physiologically selected for 
preferential growth over its cohort at a diameter of 10 mm and ultimately ovulate [53]. Most of DF 
that develop during OC use fail to ovulate, and regress by inhibition of the LH surge or the inability 
of the follicle to respond to LH due to the effects of progesterone or sensitivity of LH receptors 
[148, 150-152, 160, 161]. However, there are reports of ovulation and pregnancies during OC use 
[60, 162, 163]. The high incidence of DF development during conventional OC use suggests that the 
current OC dosing schemes does not completely suppress follicular development [164, 165]. 
Follicles which develop to pre-ovulatory diameter during OC use have similar ultrasound image 
attributes and are indistinguishable from comparable natural-cycle follicles   [151, 160]. These 
similarities can be interpreted to mean that follicles which develop during OC use have similar 
physiologic status to natural cycle follicles; therefore, ovulations can occur resulting in pregnancy 
and OC failure. During OC use, the degree of pituitary-ovarian suppression is related to the dose of 
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EE, rather than the dose and type of progestin [157, 159,  166, 167]. The maximum diameter of 
detected follicles and number of follicles observed was greater in women taking low EE dose (i.e., 
20 μg) compared to moderate EE dose OC regimens (i.e., 30-35 μg) [168, 169]. Also 20 versus 30 μg 
EE formulations have been associated with greater serum FSH and LH levels [161].  
1.3.3 Follicular development during the hormone free interval  
Conventional OC regimens were introduced in the 1960s. The dosing scheme provided a 7 
day HFI designed to induce a withdrawal bleeding each 28-day cycle and decreased exposure to 
exogenous hormones. Several years later, numerous studies have reported DF development during 
the HFI, many of which continued development to pre-ovulatory follicle status. This was 
particularly evident with low EE formulations [151, 166, 170, 171]. Approximately 85% of DF 
development is initiated during HFI and follicles > 10 mm have been ultrasonographically detected 
in this period [151, 152, 162, 172]. The HFI allows pituitary-ovarian activity to recover to levels 
observed during the early follicular phase of the natural menstrual cycle. Thus, FSH and estradiol 
levels at the end of the HFI increase and reach the levels which observed during the natural cycle 
[160, 173]. Initiation of the OC following the HFI causes a decrease in FSH regardless of the 
presence of a DF  [154]. If no DF developed during the HFI, folliculogenesis is suppressed. If a DF 
is present during the HFI, follicle growth continued despite initiation of OC and declining of FSH 
concentrations due to the decreased dependence of DF on gonadotropins [42, 148]. It has been 
reported that shortening the HFI from 7 days to 3 or 4 days or replacing some hormone-free days 
with administration of unopposed EE suppresses follicular development better than conventional 
dosing schemes [167, 171, 172, 174, 175]. A new OC regimen, in which the last 5 days of the 7days 
HFI replaced with pills containing 10 μg EE reduces follicular growth compared to the conventional 
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OC dosing scheme [171, 172]. These findings are interpreted to mean that omitting or even 
shortening the HFI increase contraceptive efficacy by decreasing the risk of DF development.  
1.3.4 Return to fertility following discontinuation of oral contraceptives  
Oral contraceptives are the only reversible contraception that inhibits ovulation by 
suppressing follicular development and ovulation [138]. Since most OC users are young women who 
have not started their families yet, it is essential to determine if OC have residual effects on ovarian 
function following discontinuation. It is apparent that women who discontinue OC commonly 
experience a two to three month delay in conception, but their infertility is transient [170, 176]. 
However, a study conducted in Malaysian women reported no difference between conception rates 
of previous OC users and previous users of non-hormonal contraception. Approximately 39%-56% 
of all previous OC users conceive within three months of discontinuation [166, 167, 169]. It has 
been reported that miscarriage rate is higher for the first 3 months following OC cessation [170, 
177]. Furthermore, 90-99% conception rates were observed within 2 years after discontinuation of 
OC. It appears that conception rates return to normal expected values within two years following 
discontinuing of OC [166, 174, 175, 178]. The delay in fertility following OC use may be due to 
continued hypothalamic suppression for a short period of time following OC discontinuation. 
Anovulation, or dysfunctional ovulation following discontinuation of OC, may account for the delay 
in fertility; however, approximately 98% of women ovulate within three months following 
discontinuation of OC [166, 178]. The concentration of EE can affect the median time to 
conception, for example OC with EE doses ≥50 μg increase the median time to conception 
following discontinuation of OC by one month compared to OC containing < 50 μg EE [170]. 
Since OC containing ≥50 μg EE are no longer prescribed commonly, this factor is likely not 
responsible for the delay in fertility. A woman’s parity, previous cycle irregularity, age, and 
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behavioural factors (the timing and frequency of intercourse) can affect the delay in fertility 
following discontinuation of OC [166, 170, 179, 180]. Therefore, the delay in fertility is due to a 
combination of both biological and behavioural factors. Further research is needed to determine the 
exact mechanisms of action responsible for the delay in fertility following discontinuation of OC.  
1.3.5 Summary  
Recently, oral contraceptives have undergone significant changes. These changes have 
focused on maintaining contraceptive efficacy and reducing adverse effects. They include 
progressive reduction of the ethinyl estradiol (EE) dose, development of new progestins, phasing 
the level of hormonal treatment, and extending the duration of hormonal exposure. It appears that 
reducing the estrogen dose to minimize adverse effects may cause lower follicular suppression 
effects, particularly during the HFI. It is currently unknown why some follicles ovulate during OC 
use while others regress. It has been well established that following OC discontinuation a two to 
three month lag in fertility occur compared to non-hormonal contraceptives. At this time there are 
no acceptable hypotheses to explain the delay in fertility following discontinuation of OC. A better 
understanding of the exact effects of OC on the reproductive organs would likely assist in the 
explanation of the delay in fertility following discontinuation of OC. Studies are required to provide 
insight into the mechanisms responsible for ovarian and uterine suppression during OC use. 
Computer-assisted quantitative echotexture analysis of ultrasound images accurately reflected 
the functional and endocrine characteristics of dominant and subordinate follicles at specific stages 
of development and regression. Based on findings in animal studies, computer-assisted image 
analysis can be developed as a safe and non-invasive technology to evaluate human ovaries.  
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Chapter 2 
2. OBJECTIVES AND HYPOTHESES 
The objectives of the studies contained in this thesis were to: 
1) Determine if, and when, human preovulatory (dominant) follicles may be prospectively    
identified from others in their cohort in vivo using computerized image enhancement and 
analysis; 
2) Evaluate differences in image attributes of DF and SF1 of major anovulatory waves; 
  3) Elucidate differences in image characteristics of ovulatory and anovulatory DF of the 
same cycle; 
4) Compare ultrasonographic image attributes of ovulatory DF of natural cycles with those 
that developed following OC discontinuation; and,  
5) Evaluate ultrasonographic image attributes of DF and SF1 of the first cycle following 
discontinuation of conventional and continuous oral contraceptive regimens.  
The corresponding research hypotheses were tested: 
1) Image attributes of the ovulatory DF would differ quantitatively from those of atretic 
(subordinate) follicles in the same cohort; 
2) Image attributes of anovulatory DF quantitatively would differ from SF1 in the same 
cohort; 
3) Image characteristics of the ovulatory DF differ from anovulatory DF in the same cycle; 
4) Ultrasonographic image attributes will differ between DF of natural cycles and DF of the 
first cycle following OC discontinuation; and, 
5) Ultrasonographic image attributes of dominant and SF1 will differ between the first 
cycles following discontinuation of continuous versus conventional OC regimens.  
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Chapter 3 
3. ULTRASONOGRAPHIC IMAGE ANALYSIS OF OVARIAN FOLLICLES DURING 
THE HUMAN MENSTRUAL CYCLE 
3.1 Abstract 
Background: Morphologic characteristics obtained by ultrasonography are not easily quantitated by 
the human eye. Computer-assisted image analysis overcomes subjective human evaluation of 
ultrasonographic images. The objectives of this study were to test the hypotheses that 
ultrasonographic image analyses would allow: 1) prospective identification of the follicle destined to 
become the ovulatory follicle from others in its cohort; 2) there are differences in image attributes of 
dominant and 1st subordinate follicles of the same cohort from ovulatory and anovulatory major 
waves; and 3) there are differences between ovulatory and anovulatory dominant follicles of major 
waves. Identification of the timing of preovulatory selection is a key component in understanding 
natural ovarian function, ovarian suppression for contraception, and improvement of ovarian 
superstimulation protocols. 
Methods: Daily ultrasonographic images obtained from healthy women of reproductive age (range 
18-40 years) recorded in a previous study  [53] were analyzed to determine timing of dominant 
follicle selection. Follicular walls and antra of dominant and 1st subordinate follicles (n=30) from 
major ovulatory waves (experiment 1), as well as dominant (n=8) and 1st subordinate follicles of 
major anovulatory waves (experiment 2) were analyzed using custom designed software 
(SYNERGYNE 2©, Saskatoon, SK, Canada). Differences in image attributes between 1st 
subordinate and dominant follicles were compared using repeated measure ANOVA (PROC 
MIXED). 
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Results: Physiologically-selected dominant follicles were retrospectively identified by the difference 
in their diameters 7 days before ovulation (p<0.0001). In experiment 1, image attributes of the 
follicle antrum and wall in major ovulatory waves exhibited higher numerical pixel value (NPV; 
p<0.0001) and pixel heterogeneity (PH; p<0.0001) in 1st subordinate compared to dominant 
follicles, started 9 days before ovulation. In experiment 2, image attributes of anovulatory dominant 
follicles demonstrated higher NPV (p=0.0208) and PH (p=0.0046) in the antrum and higher NPV 
(p=0.0002) and PH (p=0.0033) in the wall compared to ovulatory dominant follicles, which was 
detected approximately 6 days after wave emergence and continued until the day of ovulation.  
Conclusion: Our results supported the hypothesis that dominant follicles may be prospectively 
identified from the follicular cohort using computer-assisted analyses of ultrasonographic images. 
Furthermore, image analyses can be used to differentiate anovulatory versus ovulatory dominant 
follicles.  
3.2 Introduction 
The introduction of ultrasonography in the 1980’s provided an unprecedented opportunity 
to visualize the inner workings of the reproductive system. Non-invasive imaging-based techniques 
have made it possible to monitor reproductive organs sequentially in living animals and humans, and 
it remains the only in vivo method for directly assessing ovarian function [108]. However, as a 
research and diagnostic tool, ovarian ultrasonography is limited due to: 1) inter-observer variability; 
2) the need for serial evaluations to elucidate ovarian status [133, 134]. Recent advances in 
ultrasonographic techniques and development of computer-assisted image analysis tools have 
overcome some of the subjectivity of image assessment. Image analysis has been used to 
characterize several quantitative indicators of physiological function of ovarian structures in 
domestic animal models and humans [108, 131, 133, 180].  
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Practical and ethical limitations prohibit detailed study of the hormonal microenvironment 
and physiologic status of follicles in humans. However, the bovine model has been useful for 
understanding human folliculogenesis since there are similarities in the size, morphology, physiology, 
and pathology of the ovaries in cows and women [95, 97, 103, 108, 133, 135]. Women and mares 
also share similarities in the development of minor and major follicular waves during the ovarian 
cycles. Therefore, comparative studies with the equine model have enhanced our understanding of 
folliculogenesis [53, 54, 95, 103, 181-184]. 
The use of computer-assisted analysis of ovarian follicles has been validated in vitro in the 
bovine model by Singh et al. (1998) [133]. The physiologic status and phase specific changes in image 
echotexture analysis of follicles and steroid hormone content of follicular fluid were characterized. 
Tom et al. (1998) quantified pixel values of follicles in vivo [135]. Significant, temporal changes were 
found in the ultrasound image echotexture of the follicle wall and antrum during the bovine estrous 
cycles which were associated with developmental phase. These findings were in agreement with 
histological changes of ovulatory and atretic follicles determined by histology and endocrine studies 
[133, 229].  
Selection of the dominant follicle (DF) in cattle becomes manifest when the largest follicle is 8.5 
mm, 22.5 mm in mares, and 10 mm in women [15, 54]. In heifers, administration of FSH for 2 days 
before the time of selection of DF delayed the time of DF divergence from SF [230]. However, there is 
biochemical evidence that selection of DF may occur prior to morphological selection (divergence in 
diameter). Rivera et al. (2003) examined a group of follicles in cattle before divergence of the DF and 
1st subordinate follicle (SF1) based on when the follicles were 7 mm in diameter or less. An increase 
in proteolytic activity in IGFBP-4/-5 (PAPP-A) and in estradiol elaboration occurred prior to DF 
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selection. It was suggested that the increased PAPP-A degraded IGFBP-4 and -5, freeing more IGF 
to act synergistically with FSH and increase estradiol production in the future DF [185].  
Early histological studies of human ovaries obtained surgically documented that estrogen 
secretion increases in proportion to the growth of DF ≥8 mm in diameter [49]. Gougeon (1989) 
reported that follicles are selected at 5 to 8 mm in diameter, based on a higher granulosa cell mitotic 
index in the largest healthy follicle compared with other follicles of the cohort [14]. Macklon and 
Fauser (1999) and Pache et al. (1990) reported the first appearance of the DF at mean size 10 ± 3 
mm. Van Dessel et al. (1996) showed that increased aromatase enzyme activity occurs only in 
selected DF, with intrafollicular estradiol concentrations rising only in follicles greater than 9 mm in 
diameter [51, 56, 57].   
Current work in our laboratory has focused on elucidating human ovarian physiology during 
the menstrual cycle. Recently, Baerwald et al. (2003) identified wave-like patterns of follicular growth 
and development in human ovaries during the menstrual cycle. Sixty eight percent of women 
exhibited 2 waves and 32% exhibited 3 waves of follicular development during an ovarian cycle. The 
final wave of each cycle resulted in ovulation of a dominant follicle. All preceding waves were either 
minor or major anovulatory waves [53]. Major waves were those in which a single DF was selected 
to grow larger than all other SF of the cohort. Minor waves are defined as those that selection of DF 
was not manifest. Follicle selection is characterised by a divergence in the growth profiles of DF and 
SF1 when the DF is 2 mm larger than SF1 in diameter [53, 188]. 
Physiologic selection of DF remains one of the great mysteries in reproductive biology. It 
has been recently demonstrated that in approximately 30% of women there may be 2 or 3 times 
during the cycle when selection of a DF is manifest [53, 188]. That is, DF selection may occur 1 or 2 
times during the cycle before the ultimate selection of the ovulatory follicle, depending on whether 
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the individual woman has 2 or 3 major waves of follicle development [1]. Accordingly, we wished to 
determine if the selected follicles exhibited image attributes reflective of their physiologic status. Our 
rationale was that all DF would exhibit similar attributes during the early phases of their 
development. Approximately 23% of ovarian stimulations as a treatment for anovulation fail due to 
inadequate ovarian response [189]. Evidently, better control of ovarian response is necessary which 
might be influenced by the status of the DF at the time stimulatory treatment is initiated. Rapid non-
invasive assessment of the physiological status of individual follicles represents a tremendous 
advance in the diagnosis and management of many aspects of fertility, infertility and evaluation of 
different therapeutic inventions.  
The primary objective of the present study was to determine if and when the human 
preovulatory (dominant) follicle may be prospectively identified from others in its cohort during the 
ovulatory wave in vivo using computerized image enhancement and analysis. We hypothesized that 
image attributes of the DF would differ from the SF1 of the same cohort. Secondary objectives were 
to evaluate differences in image attributes of DF and SF1 of anovulatory major waves and to assess 
differences in image attributes of ovulatory DF compared to anovulatory DF of the same cycle. We 
hypothesised that image attributes of anovulatory DF would differ from SF1 and that the ovulatory 
DF would differ from anovulatory DF. 
3.3 Materials and methods 
The study was a retrospective analysis of ultrasound images obtained in a previous study 
designed to characterize ovarian follicular wave dynamics during natural cycles. Participants in the 
original study included 50 healthy women of reproductive age (mean + SD = 28.0 + 6.9 years, range 
= 19 - 43 years). High-resolution ATL Ultramark 5 - 9 HDI and HDI 5000 ultrasound machines 
with 5-9 MHz multi-frequency convex array transducers (Advanced Technologies Laboratories; 
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Bothell, WA, USA) were used to acquire images. The study protocols for the original and current 
studies were approved by the University of Saskatchewan Biomedical Research Ethics Board [53, 
190]. 
In the original study, follicular development in each ovary was monitored by daily 
transvaginal ultrasonography for one IOI (inter-ovulatory interval). An IOI was defined as the 
interval from one ovulation to the following ovulation. Ovulation was defined as the disappearance 
of the largest follicle (>15 mm) that had been identified by ultrasonography and the subsequent 
visualization of a corpus luteum [53]. Wave emergence was defined as the day on which the largest 
follicle of the wave was first identified at 4 to 5 mm.   
The location and diameter of individually-identified follicles (> 4 mm) and corpora lutea 
were recorded each day. Images were recorded digitally and transferred to a customized database 
during the ultrasound examinations. The dominant follicle was defined as the largest follicle of the 
wave and the SF1 was defined as the second largest follicle of the same wave. Major waves were 
defined as waves in which one follicle grew to ≥10 mm and grew larger than the next largest follicle 
by ≥ 2 mm. Minor waves were defined as those in which the largest follicle developed to < 10 mm 
and did not exceed other follicles of the wave by ≥2 mm. Physiologic selection was defined as the 
first day of divergence in the diameter of the DF and SF1 in their follicle growth profiles. Ovulatory 
major waves were those in which the DF ovulated, while in anovulatory major waves the fate of the 
DF was atresia [188]. Daily images of DF and SF1 of each ovulatory major wave were identified 
retrospectively from day of ovulation to the day of wave emergence at 4 -5 mm. Images selected for 
analysis were obtained at the largest cross-sectional diameter with the fewest image artifacts. All 
image analyses were performed by the same individual (ER). 
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Image attributes of DF and SF1 were analyzed using customized software optimized for 
ultrasonography (SYNERGYNE 2©, Saskatoon, SK, Canada). Three different techniques were 
applied: 1) spot analysis; 2) line analysis; and, 3) region analysis. All were designed to quantify gray-
scale values of selected areas of an image [131]. Three quantitative image attributes were evaluated: 
1) numerical pixel value (NPV), defined as the mean gray-scale value of the sampled pixels; 2) pixel 
heterogeneity (PH), defined as the standard deviation of the gray-scale values of the sampled pixels; 
and, 3) the region selected volume (RSV) defined as sum of the brightness of all of the pixels within 
the selected area (GSV/mm2) [108]. 
In spot analyses, the follicle antrum was divided into 4 quadrants and pixel values from each 
region were measured by a computer-generated circle (15 pixels in diameter). Follicle wall pixel 
values were obtained by placing 4 small circles, each measuring 2 pixels in diameter, on the wall of 
each follicle. Spots were placed at the 2, 4, 8, and 10 o’clock positions to minimize specular 
reflection artifacts. Antral and wall NPV and PH were obtained as an average of the 4 
measurements. For all analyses, images were normalized using the maximum and minimum pixel 
values from the gray-scale bar generated by the ultrasound instrument [133]. Line analysis was used 
to measure the NPV and PH values of pixels along a line placed across a specified section of the 
follicle wall. A 2-dimensional graph of the numerical pixel values was produced that depicted the 
intensity of the echoes located along the line. Four lines were drawn from the antrum-wall interface 
to the stroma. The antrum-wall interface was defined as the last pixel along the line after which a 
sequential rise in gray-scale occurred [131]. The second sudden rise in grey-scale values along the line 
was representative of stroma interface. The 4 lines were located at the 2, 4, 8, and 10 o’clock 
positions of the follicle wall to avoid enhanced through-transmission, refraction and shadowing 
artifacts. NPV and PH of each follicle wall were reported by averaging the values for 4 lines for each 
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image. The values for the lines comprising the mean differed slightly in length based on follicle wall 
thicknesses at each of the locations. 
Region analyses involved overlaying a computer-generated pixel-by-pixel mesh onto a 
selected area to generate a 3-dimensional framework representing pixel values. A computer-
generated surface was then placed over the framework to produce a topographical image. Color 
shading was applied to enhance visual appreciation. The antrum-wall interface was used to outline 
the internal border of the follicle wall. The visually detectable margin between follicle wall and 
peripheral stroma was used to outline the identify border of the follicle wall. This technique 
enhanced rapid visual assessment of ultrasonographic attributes associated with follicle viability and 
atresia and made the numeric data easier to visualize [111]. The area selected for region analyses 
were used to measure NPV, PH and RSV for the entire follicle and follicle wall. In current study, 
first the whole follicle was analyzed and then follicle walls were isolated for evaluation.  
Experiment 1: Daily sequential images of the individually-identified DF and SF1 were used 
for the analyses. Images of DF (n=30) and SF1 (n=30) were analyzed and data were centralized to 
the day of ovulation.  
Experiment 2: Images of individual DF (n=8) and SF1 (n=8) of major anovulatory waves 
and DF (n=8) of ovulatory waves were evaluated. Only 8 of the 30 women (26%) in the previous 
study exhibited major anovulatory waves. Data were centralized to the day of wave emergence.  
Image attributes were compared using repeated measures analysis of variance (PROC 
MIXED, SAS, Version 9) for main effects of follicle type, day, and follicle by day interaction. 
Significance was set at p< 0.05. Results are expressed as the mean ± SEM.  
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A
3.4 Results 
3.4.1 Experiment 1 
3.4.1.1 Dominant follicles versus first subordinate follicles of ovulatory major waves 
Mean diameter profiles of the DF and SF1 in major ovulatory waves are presented (Figure 
3.1, A). The mean diameter of DF was 21.1 ± 1.1 mm on Day –1 (Day 0 = day of ovulation). On 
the day of divergence, the DF was 10.4 ± 0.3 mm and the SF1 was 8.3 ± 0.3 mm in major ovulatory 
waves, as previously documented [188]. The DF became larger (p<0.0001) than the SF1 7 days 
before ovulation. 
Spot analysis of follicle antrum and wall:  Evaluations of NPV and PH of the antral fluid images 
by spot analysis are shown (Figure 3.1: B, C). Numerical pixel values were higher in SF1 than DF 
(p<0.0001). Differences were detected from day -9 to day 0 (i.e., 9 days before ovulation to day of 
ovulation; p=0.0013). Heterogeneity of the follicle fluid was higher in SF1 than DF (p<0.0001). 
Pixel heterogeneity of SF1 antra increased as the follicle regressed, whereas antral heterogeneity of 
DF decreased as the interval to ovulation decreased. Follicle by day interaction was attributed to a 
greater decrease in NPV (p=0.0061) and PH (p<0.0001) as the interval to ovulation decreased 
(greater in which follicle?). Spot analysis of the follicle wall demonstrated higher NPV in SF1 
compared to DF (p=0.0002). The follicle by day interaction was not different (p=0.6045). Pixel 
heterogeneity was similar between SF1 and DF (p=0.1829). 
Line analysis of follicle wall: Numerical pixel values for the follicle wall were higher (p<0.0001) in 
SF1 compared to DF and NPV of DF progressively decreased as the DF neared ovulation. This 
difference began 10 days before ovulation and continued until the day of ovulation (p=0.0274). Pixel 
heterogeneity of the follicle wall was higher in SF1 compared to DF, (p<0.0001; Figure 3.1, D). 
Differences between PH of follicle walls were first detected 9 days before ovulation (P=0.0214; 
Figure 3.1, E). 
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Figure 3.1: Mean  follicle diameter (A), NPV (B), PH (C) of the antrum obtained by spot analysis, 
and NPV (D), PH (E) of the wall obtained by line analysis of dominant (○; n=30) and 1st 
subordinate (●; n=30) follicles of ovulatory waves (*=first day of significant difference). Data are 
represented as the mean + standard error. 
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Region analysis of follicles: Numerical pixel values were greater in SF1 compared to the DF 
(p=0.0003). Interactions (p=0.3717) between follicle type and day were not observed. There were no 
differences in PH (p=0.1043) between DF and SF1 (Figure 3.2, A, C, E).  Volume of the selected 
region (RSV) was greater (p<0.0001) in DF than SF1 beginning 8 days before ovulation (p<0.001).   
Region analysis of the follicle wall: Numerical pixel values of the follicle wall were greater in DF 
compared to SF1 (p=0.001) beginning on day -6 (p=0.0009). Pixel heterogeneity exhibited a similar 
pattern with higher values (p=0.0182) in DF starting 6 days before ovulation (p=0.01; Figure 3.2, B, 
D, F). DF showed higher RSV (p<0.0001) compared to SF1 beginning 8 days before ovulation 
(p<0.001).  
Three-dimensional color images representing the whole follicle and follicle wall obtained by 
the regional analysis tool were examined visually for qualitative differences between DF and SF1 
(Figures 3.3, 3.4). Apparent differences observed were: 1) a less defined and irregular follicular-wall 
in SF1; 2) a sharply defined wall with a distinct boundary from the antrum of the DF; 3) a “rough” 
and heterogeneous antrum in SF1; and, 4) a smooth and homogenous antrum in DF.  
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Figure 3.2: NPV (A, B), PH (C, D), and RSV (E, F) obtained by region analysis of dominant (○; 
n=30) and 1st subordinate (●; n=30) follicles of major ovulatory waves (*=first day of significant 
difference). Region analyses for the entire follicle (A, C, E) and follicle wall (B, D, F) are shown.  
Data are represented as the mean + standard error. 
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Figure 3.3: Three dimensional images of dominant (A, B, C) and 1st subordinate follicles (D, E, F) 
from ovulatory waves (Experiment 1) generated by the region analysis at 10 (A, D) and 8 (B, E) days 
before ovulation, and 1 day (C, F) before atresia. X and Y axes represent the length and width 
dimension of the original images. The vertical axis represents the quantitative pixel values.  
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Figure 3.4: Three dimensional images of dominant (A, B, C) and 1st subordinate follicles (D, E, F) 
wall from ovulatory waves (Experiment 1) generated by the region analysis at 10 (A, D) and 8 (B, E) 
days before ovulation, and 1 day (C, F) before the follicles become atretic. X and Y axes represent 
the length and width dimension of the original images. The vertical axis represents the quantitative 
pixel values.  
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3.4.2 Experiment 2 
3.4.2.1 Dominant follicles versus 1st subordinate follicles of anovulatory major waves 
Spot analysis of follicle antrum: The SF1 antrum exhibited higher NPV (p<0.0094) compared to 
the DF in the anovulatory major waves (Figure 3.5, A). Antral PH was higher (p=0.0049; Figure 3.5, 
B) in the SF1 than the anovulatory DF. There were no differences between anovulatory DF and SF1 
antral NPV (p=0.5710) and PH (p=0.7383) 1 day before they were no longer detected during the 
final regression phase. Both types of follicles exhibited similar attributes 1 day before they became 
atretic. 
Line analysis of follicle wall: The follicle wall exhibited higher NPV in SF1 compared to the DF 
(p<0.0001) of anovulatory major waves (Figure 3.5, C). There was no interaction between follicle 
and day (p=0.1561). Pixel heterogeneity was the same in anovulatory DF and SF1 (p=0.7791). The 
attributes of the follicle wall from anovulatory DF and SF1 were similar 1 day before their 
disappearance (NPV and PH, p=0.7450 p=0.8398, respectively).   
Three-dimensional color images of anovulatory DF and SF1 representing the whole follicle 
obtained by the regional analysis tool were examined visually. The images demonstrated: 1) a sharply 
defined wall with a distinct boundary from a homogeneous antrum of the DF 6 days after wave 
emergence; 2) a thick and less defined follicular wall and “rough” and heterogeneous antrum in 
anovulatory DF and SF1 one day before ovulation (Figure 3.6).               
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Figure 3.5: NPV (A) and PH (B) of the antrum obtained by spot analysis, and NPV (D) and PH (E) 
of the wall obtained by line analysis of dominant (○; n=8) and 1st subordinate (●; n=8) follicles of 
anovulatory waves. Data are represented as the mean + standard error. 
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Figure 3.6: Three dimensional images of dominant (A, B, C) and 1st subordinate follicles from 
anovulatory waves (Experiment 2) using the region analysis at 1 (A, D) and 6 (B, E) day after wave 
emergence, and 1 day before they become atretic (C, F). X and Y axes are in the length and width 
dimension of the original images. The vertical axis represents the quantitative pixel values.    
3.4.2.2 Ovulatory dominant follicles versus anovulatory dominant follicles of major waves 
The diameter of ovulatory DF was greater than anovulatory DF from 5 days (p=0.0063) 
after wave emergence until the end of the wave (Figure 3.7, A). Numerical pixel values of the antra 
of anovulatory DF were higher than those of ovulatory DF (p<0.0208; Figure 7, B). Pixel 
heterogeneity of the antrum was higher (p<0.0046; Figure 3.7, C) in anovulatory versus ovulatory 
DF beginning 6 days (p=0.0241) after wave emergence and continuing until they could no longer be 
identified. Changes in antral PH over time were affected by the follicle type (p=0.0346). Higher 
NPV were observed in anovulatory follicle walls beginning 6 days (p=0.0011) after wave emergence 
(p<0.0002; Figure 3.7, D) and higher PH were observed in the follicle wall of anovulatory DF 
compared to ovulatory follicles (p<0.0033; Figure 3.7, E).  
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Figure 3.7: Mean follicle diameter (A), NPV (B), PH (C) of the antrum obtained by spot analysis, 
and NPV (D), PH (E) of the wall obtained by line analysis of ovulatory dominant (○; n=8) and 
anovulatory dominant (●; n=8) follicles (*=first day of significant difference). Data are represented 
as the mean + standard error.  
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3.5 Discussion  
Our results supported the hypotheses that quantitative echotextural differences exist 
between ultrasonographic images of the DF and SF1 of major ovulatory and anovulatory waves 
during the human menstrual cycle. Differences in image attributes can be detected prior to the time 
that selection is manifest by divergence in follicular diameter.  
Our retrospective examination of follicle diameter profiles revealed that physiologic selection 
of a dominant follicle occurred 8 days before ovulation. Divergence was manifest when DF and SF1 
were approximately 10 and 8 mm in diameter, respectively; however, image attributes of the walls 
and antra were greater in SF1 and were first detected 2 days before divergence in their diameters. It 
appears that morphological differences were present before the DF was visually identified by its 
larger diameter. Our results in humans were in close agreement with results from previous studies in 
animal models in that the ovulatory follicle wall was thicker and had lower grey-scale values than 
observed in atretic follicles [104, 133].   
Our results for follicle wall spot analyses were not well correlated with the physiological 
status of follicles. Similar to antrum, spot analysis of the wall exhibited higher NPV in the SF1 than 
the DF; however, there was no interaction effect between follicle type and day and no difference in 
wall PH. The ambiguous nature of the different findings between follicle walls and antra could be 
interpreted to mean that sampling small areas within the follicle wall were not applicable to image 
attributes of the follicle wall. However, Tom et al. (1998) reported meaningful changes in 
echotextural characteristics of bovine DF walls that were reflective of status of the DF using spot 
analysis of wall. The reason for this discrepancy remains unresolved [135].  
Region analyses of the whole follicle (wall and antrum together) showed a greater NPV in 
SF1 compared to DF 6 days before ovulation unlike the results of spot and line analysis. Follicular 
56 
 
fluid and cellular components of follicle wall have different tissue properties and their characteristics 
differ during the course of follicular development in DF or SF. Therefore, it can be postulated that 
the effects of adding 2 different echotextures, antrum and wall, is not an optimal way to compare 
the attributes of DF and SF1. Region analysis of the follicle wall has also revealed a lower NPV in 
SF1 compared to DF which was not in agreement with results of spot and line analysis of follicles. It 
may be that the greater size of DF wall than SF1 wall compensates for the higher wall NPV and PH 
of SF1 compared to DF. We interpreted these inconsistencies to mean that region analysis were not 
an appropriate method to evaluate quantitative differences between DF and SF1.   
In domestic animals and humans, morphological changes indicative of atresia appeared to be 
initiated in the granulosa layers as cells were sloughed into the antrum. Conversely, preovulatory 
follicles possessed the thickest wall, lowest cell density of granulosa and thecal layers, and highest 
vascularity. This is consistent with our findings from image analysis. Ultrasound image attributes of 
bovine follicles have been observed to be highly correlated with endocrine profiles and 
morphometric characteristics of follicles. In 1998, Singh et al. reported higher NPH and PH in SF1 
compared to DF in bovine models. In addition, follicular fluid of ovulatory follicles appeared 
uniform while the fluid of anovulatory follicles was “rough” and heterogeneous [133]. The 
differences could be attributed to the changes in fluid viscosity and semi-solid components in the 
fluid, which would more apparent in the antra of anovulatory follicles. According to histological 
findings in human atretic follicles the antrum is invaded by fibroblasts. It would be logical to assume 
that shedding of granulosa cells into follicular fluid during atresia would be expected to cause a more 
heterogeneous appearance of the antrum compared to antra of non-atretic or ovulatory follicles. 
Therefore, it was concluded that changes in NPV, PH, and other values reflected histomorphologic 
changes.   
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Our hypothesis that image characteristics of anovulatory DF would differ quantitatively 
from SF1 of the same cohort and from ovulatory DF of the same cycle was supported. Higher 
values were observed in the SF1 compared to the DF anovulatory waves. Time did influence image 
attributes, but DF and SF1 were influenced in the same way. Quantitative values of anovulatory DF 
walls and antra increased 3 days before the follicles were no longer identifiable (become atretic) and 
reached the same values of the SF1 one day before they regressed. Anovulatory DF showed higher 
NPV and PH compared to ovulatory DF. These findings demonstrated that for the first few days of 
anovulatory waves, DF and SF1 have the same image attributes, DF diverge from the cohort in the 
middle of the wave (6 days after wave emergence) and acquire DF characteristics, but acquired 
characteristics of atresia at the end of the wave. These findings were consistent with our 
observations of DF and SF1 of ovulatory waves, except for the fate of DF which is atresia. 
Although ovulatory and anovulatory DF were physiologically selected and attained dominance, they 
exhibited different image characteristics throughout their lifespans. Continued investigations are 
needed to assess the physiologic status and ovulatory potential of DF of anovulatory waves.  
The study of ovarian follicular dynamics using ultrasonographic image analysis tools is a 
relatively new research area with profound clinical relevance. Understanding the precise timing of 
morphological changes indicative of physiological status such as selection, ovulation, and atresia is 
expected to help improve stimulation protocols and help to reduce the overall amount of 
pharmaceutical intervention as the protocol could be tailored to the ovarian response of individual 
patient. Incorporating image analysis tools within the ultrasound instrument could easily provide a 
more efficient technique to evaluate ovarian physiology and manage clinical observations in vivo.  
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Conclusion  
Quantitative analyses of DF and SF1 in human ovulatory follicle waves reflect their 
physiologic status and are in agreement with animal studies. Values for the antrum and wall were 
noticeably low in preovulatory DF, presumably due to a smooth and clear antrum fluid and higher 
vascularity of the wall. In addition, echotextural attributes of SF1 appeared to reflect histological 
changes associated with atresia, such as shedding of the granulosa cells into the antrum. Our results 
revealed that quantitative echotextural changes occurred before the time of divergence of DF from 
the cohort. The anovulatory DF demonstrates different attributes compared to the SF1 regardless of 
their identical ultimate destiny which is atresia. Dominant follicles of ovulatory and anovulatory 
waves were exhibited different echotextural attributes. Ovulatory DF exhibited lower values 
compared to anovulatory DF. Thus, the ultrasound image attributes of follicles can be used as a 
non-invasive indicator of follicle viability and health. 
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Chapter 4 
4. ULTRASOUND IMAGE ATTRIBUTES OF HUMAN OVARIAN FOLLICLES 
FOLLOWING DISCONTINUATION OF CONVENTIONAL AND CONTINUOUS 
ORAL CONTRACEPTION  
4.1 Abstract 
Objective: To test the hypotheses that: 1) dominant follicles of natural cycles would quantitavely 
differ from those that developed following OC discontinuation; and, 2) image attributes of 
dominant (DF) compared to 1st subordinate (SF1) follicles would differ following conventional and 
continuous OC regimens.  
Methods: Ultrasonographic images obtained from healthy women of reproductive age recorded in 
previous studies were analyzed to determine differences in image attributes of ovulatory DF 
developed during natural menstrual and 1st cycle following OC discontinuation. The images were 
also analyzed to evaluate changes related to selection of the DF from its cohort in the first wave 
following OC discontinuation. Dominant (n=24) and 1st subordinate (n=24) follicles from the first 
wave following OC discontinuation, and DF of natural major ovulatory waves (n=24) were 
compared in a retrospective study. Ultrasonographic images of the follicular walls and antra were 
analyzed with 2 different techniques (spot and line analyses) using custom designed software 
(SYNERGYNE 2©, Saskatoon, SK, Canada). Numerical pixel values (NPV) and pixel heterogeneity 
(PH) of the wall and antrum were quantified. Differences in image attributes between DF and SF1 
were assessed by general linear models repeated measure ANOVA. Statistical tests were set at the 
95% significance level.  
Results: Higher NPV (p<0.0001) and PH were observed in the antrum (p=0.002) and NPV 
(p<0.0001) in the wall of DF which developed following OC discontinuation compared to those of 
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natural cycles. No differences were observed in NPV and PH of DF that developed following 
discontinuation of conventional versus continuous OC regimens. Nor were there differences among 
image attributes of the SF1 developed following discontinuation of either OC regimen. Higher NPV 
and PH were observed in the antrum (p<0.0001 and p<0.0001, retrospectively) and wall (p<0.0001 
and p<0.0001, retrospectively) of SF1 compared to DF following OC use regardless of their 
regimen.  
Conclusion: Differences between image attributes of DF that developed following OC termination 
and DF of natural cycles were detected; thereby supporting our primary hypothesis. No differences 
were observed in image attributes of DF versus SF1 that developed following discontinuation of 
conventional versus continuous OC regimens. Thus, our secondary hypothesis was not supported. 
Computer-assisted image analyses may be useful for predicting physiologic status of follicles and 
may improve our understanding of factors responsible for the fertility delay or increased miscarriage 
rate following OC discontinuation.  
4.2 Introduction 
The biochemical structures of the reproductively active steroid hormones were determined 
in the 1930’s [191]. Subsequently, it was learned that high doses of estrogens or progesterone could 
inhibit ovulation [192]. In 1960’s, the U.S. Food and Drug Administration (FDA) approved the use 
of Enovid™ 10 mg (9.85 mg norethynodrel and 150 µg mestranol) for menstrual disorders and later 
as the first oral contraceptive (OC). All currently marketed OCs combine ≤35 μg ethinyl estradiol 
(EE) with a synthetic progestin [191, 193]. Several generations of combined OC utilizing orally 
active EE and several different progestins have been used by millions of women worldwide. Oral 
contraception is one of the most effective, tolerable and reversible methods of contraception [139, 
145, 150, 161, 194-197].  
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Combined OC are designed to prevent folliculogenesis and ovulation. Estrogens have been 
shown to inhibit the growth of both preantral and medium-sized antral follicles in primates [198]. 
Concurrently, the progestin component acts to reduce LH pulsatility and amplitude of the 
preovulatory LH surge, thicken cervical mucus, decrease tubal mobility, and inhibit endometrial 
development [197]. The conventional OC administration scheme was designed to mimic natural 
menstrual cycles, permitting approximately 4 days of menses every 28 days. A 7-day pill free interval 
is required to allow 4 days of menstrual bleeding. Therefore, the conventional dosing regimen is 
comprised of 21 hormonally active pills, followed by a 7-day hormone free interval (HFI) [199]. 
It has recently become clear that conventional dosing schemes do not completely suppress 
folliculogenesis and ovulation [151, 152, 154]. There are reports that ovulation does occur during 
OC use, but most DF regress or form anovulatory cysts [151, 200]. Follicular development during 
the HFI was attributed to quick recovery of the hypothalamic-pituitary-ovarian axis leading to 
elevated levels of FSH [14, 20, 34, 55, 201, 202]. During the HFI, FSH rises above the threshold 
required for initiation of a new follicle wave [151, 164, 171, 203]. Consequently, follicles may 
continue to develop and produce estradiol, even when OC use is reinitiated following the HFI [151, 
196, 201]. The dominant follicles which develop during OC administration show ultrasonographic 
characteristics similar to those of comparable natural-cycle follicles [149, 190]. It has therefore been 
suggested that follicles which develop during OC administration exhibit physiologic status similar to 
those that develop during natural cycles. 
New dosing methods have recently been developed to suppress monthly menses with 
continuous administration of OC for 3, 6 or 12 months followed by a 7-day HFI. Loudon et al. 
(1977) reported that women accepted suppression of monthly menstruation using 3 months of 
continuous OC [204]. Shortening or removing the HFI has been shown to increase OC efficacy 
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[149, 162-164]. Killick et al. (1998) reported that the addition of 5 days of 10 mcg EE during the 
traditional 7-day HFI more effectively suppressed ovarian follicular activity than conventional 
regimens [150]. Schlaff et al. (2004) compared women on 3 different regimens and demonstrated that 
continuous OC use provided better follicular suppression compared to the conventional dosing 
scheme with a 7-day HFI or with 5 days of low-dose estrogen added to the usual HFI [163]. Birtch et 
al. (2006) recently demonstrated that a continuous OC regimen more effectively prevented follicle 
development, dominant follicle selection, and breakthrough ovulation [171].  
Reversibility of contraceptive methods is of interest to many OC users since most are young 
women who have not started their families. It has been suggested that OC users may experience a 
slight delay in regaining fertility compared with those who have not used contraception or were 
previous users of non-hormonal contraceptive methods [170, 173, 174, 177, 205-207]. Ovarian 
suppression continues following OC cessation, which decreases the conception rate. The length of 
ovarian suppression following OC withdrawal varies among women. However, OC do not 
permanently affect fertility in previous users [166, 170, 173]. Parity, previous menstrual disorders, 
the concentration of EE in the OC, duration of OC use, behavioural factors, and age are all 
important factors that can affect the delay in fertility following OC discontinuation [166, 170, 174, 
205]. It has been shown in our laboratory that the selection of DF took 3 days longer, dominance 
was manifest 2 days later, and it took approximately 5 days longer for follicles to ovulate once OC 
were discontinued compared to natural cycle follicles [171]. The occurrence of miscarriage also is 
reportedly higher in the first 3 months following OC cessation [169, 176].  
Ultrasound image echotexture reflects the histological structure of the tissue [208]. Each 
digitally acquired image is composed of thousands of discrete picture elements, or pixels, in 1 to 256 
shades of gray from black to white [208]. The human eye can discriminate a limited number of 
shades of gray, which reduces the precision of tissue characterization. To overcome limitations of 
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visual assessments of ultrasonographic images, a computer-assisted image analysis technique was 
developed in our laboratory to allow quantification of ultrasound images [108, 131, 133, 136]. 
The objectives of the present study were to evaluate ultrasonographic image attributes of DF 
that developed following OC discontinuation with those of natural cycles and to compare DF and 
SF1 of the first cycle following discontinuation in conventional and continuous OC regimens. We 
hypothesized that ultrasonographic image attributes would differ between DF of natural cycles and 
DF of the first cycle following OC discontinuation. We further hypothesized that image attributes of 
DF versus SF1 would differ during the first cycle following discontinuation of continuous versus 
conventional OC regimens. 
4.3 Materials and methods 
This study was a retrospective and observational. The images were obtained in 2 previous 
studies designed to: 1) characterize ovarian follicular dynamics during and after continuous versus 
conventional dosing schemes of OC; and, 2) characterize ovarian follicular wave dynamics during 
natural cycles [53, 190]. Participants were healthy women of reproductive age (24.5 ± 0.02 years, 
mean ± SEM). The study protocols were approved by the University of Saskatchewan Biomedical 
Ethics Review Board.  
In both studies, ovulation was defined as the disappearance of a follicle ≥15 mm in diameter 
detected ultrasonographically the previous day followed by the subsequent visualization of a corpus 
luteum [92, 121]. Selection was defined as the first day the DF exceeded the diameter of the SF1 by 
> 2 mm [53]. High-resolution ATL Ultramark HDI 5000 ultrasound machine with 5 - 9 MHz multi-
frequency convex array transducers (Advanced Technologies Laboratories; Bothell, WA, USA) were 
used to acquire follicular data in both studies [188, 190]. Follicle growth rates (mm/day) were 
determined over time in both studies by: [maximum follicle diameter – minimum follicle 
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diameter]/number of days of growth. This experiment consisted of 3 study groups. In the first 
group, sequential images of DF (n=12) and SF1 (n=12) from the first cycle after conventional OC 
regimen discontinuation were evaluated. The second group consisted of DF (n=12) and SF1 (n=12) 
images from the first cycle following discontinuation of continuous OC dosing regimen. The third 
group was comprised of sequential images of DF (n=24) from 30 individuals during the menstrual 
cycle study. Women whose data sets analyzed randomly were selected from the complete set of data 
from original studies. 
Natural cycle study 
Participants were healthy women (n = 30) of reproductive age (mean + SEM= natural cycles 
28.0 + 6.9 years). Each woman’s ovaries were imaged daily for 1 complete IOI (inter-ovulatory 
interval). An IOI was defined as the interval from one ovulation to the following ovulation [53].  
Oral contraceptive study 
Women (n = 36) received one of 2 monophasic OC formulations in either a continuous or 
conventional dosing scheme for 3 sequential 28-day dosing cycles [171]. In all groups, OC were 
initiated on the first day of menses during cycle 1. The conventional regimen consisted of 21 days of 
hormonally active pills followed by a 7-day hormone free interval (HFI). The continuous regimen 
consisted of 28 daily active pills with no HFI. The 4 study groups were: 1) 30 μg EE /150 μg 
levonogestrel (LNG) (21 days and 7 day HFI; n=8); 2) 30 μg EE/150 μg LNG (28 days; n=9); 3) 35 
μg EE/250 μg norgestimate (NGM; 21 days and 7 day HFI; n=8); and, 4) 35 μg EE /250 μg NGM 
(28 days; n=11). 
Women did not take OC during the fourth and final cycle of the study. Cycle 4 day 1 was 
defined as the first day following discontinuation of OC. Ultrasound examinations for cycle 4 began 
on the second day of the cycle and were continued every second day. Daily ultrasound examinations 
were initiated when a follicle reached ≥16 mm in diameter and continued until the physiologic fate 
of the follicle was determined (ovulation or atresia).   
Image analysis 
  Image attributes of follicles were analyzed using a graphics workstation equipped with 
customized software optimized for ultrasonography (SYNERGYNE 2©, Saskatoon, SK, Canada). 
Spot analysis and line analysis techniques were applied as described by Pierson et al. (1995) and 
Rezaei et al. (2009) [108, 136]. Numerical image attributes of the wall and antrum were quantified by 
using spot, line, and region analysis techniques. Numerical pixel value (NPV) was defined as the 
mean pixel gray-scale value of the sampled pixels, and pixel heterogeneity (PH) was defined as the 
standard deviation of the mean gray-scale values of the sampled pixels [108, 131, 133, 136].  
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B
In spot analyses, the follicle antrum was divided into 4 quadrants and pixel values from each 
region were measured by 4 computer generated spots approximately 15 pixels in diameter. Antral 
NPV and PH were obtained as an average of the 4 measurements. Line analysis was used to measure 
the NPV and PH values of pixels located along a 1 pixel wide line which was placed across the 
follicle wall. Mean pixel value and pixel heterogeneity of each follicle wall were obtained by 
averaging the values for 4 lines per image. Region analyses involved selection of the area of interest 
using a one-pixel-wide line to outline the external and internal follicular wall with the fewest image 
artifacts. Then a computer-generated pixel by pixel mesh was overlaid onto the area to generate a 3-
dimensional framework representing processed pixel values. A computer-generated surface was 
placed over the framework to produce a topographical image. Color shading was applied to make 
subtle differences in the surface contours more visible [108, 131, 133, 136].  
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Image attributes of both experiments were compared using repeated measures analysis of 
variance (PROC MIXED, SAS/STAT, Version 9) for main effects of follicle type, day, and follicle 
by day interaction. Significance was set at p< 0.05. Results are expressed as the mean ± SEM. 
4.4 Results 
4.4.1 Ultrasound image characteristics during continuous and conventional OC regimens 
Data for all endpoints were analyzed initially to examine differences between the continuous 
versus conventional dosing schemes. No differences were observed in: 1) antral and wall NPV of 
DF (p=0.1453, and p=0.4876, respectively); 2) antral and wall NPV of SF1 (p=0.5848, and 
p=0.2261, respectively); 3) antral and wall PH of DF (p=0.1813, p=0.0502, respectively); 4) antral 
and wall PH of SF1 (p=0.2865, and p=0.7671, respectively) in follicles developed following 
discontinuation of conventional and continuous dosing schemes using spot analysis of the follicle 
antrum and line analysis of follicle wall. Consequently, data obtained from the first cycle following 
discontinuation of conventional and continuous OC regimens were combined.  
4.4.2 Ultrasound image characteristics of dominant follicles of natural cycles versus the first 
cycle following OC discontinuation  
Image attributes of DF from natural cycles were compared to those of the first cycle 
following OC discontinuation. There were no differences between diameter profiles of DF that 
developed following OC discontinuation and DF of natural cycles through their developmental 
stages (p=0.3563); although, their growth rates were different (p=0.0019; 1.4 mm/day and 1.2 
mm/day in natural cycles and OC cycles, respectively) (Figure 4.1: A).  
No differences were observed by visual assessments of ultrasound images of dominant 
follicles from either group; although, numerical values obtained by the region analysis technique 
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were higher in DF that developed following OC compared to those of natural cycles (NPV 
p<0.0001; SD p<0.0001; Figure 4.2). Dominant follicles that developed following OC 
discontinuation had a higher NPV (p<0.0001) and PH (p<0.0022) in antral fluid compared to DF of 
natural cycles (Figure 4.1: B & C). Higher NPV (p<0.0001) were also detected in the walls of DF 
following OC termination compared to DF of natural cycle (Figure 4.1: D). There were no 
differences in wall PH (p=0.1533) between DF that developed following OC termination compared 
to DF from natural cycles.  
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Figure 4.1: Mean follicle diameter (A), NPV (B) and PH (C) of the antrum obtained by spot 
analysis, and NPV (D), PH (E) of the wall obtained by line analysis of the dominant follicle that 
developed following OC discontinuation (●; n=24) and the dominant follicle of the natural cycle (○; 
n=24). Data points are represented as the mean ± standard error. 
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Figure 4.2: Ultrasonographic images and visual assessment (region analyses) of preovulatory 
dominant follicles using the region analysis. Dominant follicle of the first cycle following OC 
discontinuation (A, C) and ovulatory dominant follicle of natural cycle (B, D) are shown. Both 
dominant follicles share the same visual ultrasonographic characteristics and show a sharply defined 
wall with a distinct boundary from the smooth and homogenous follicular fluid and antrum. C, D 
represents 3-dimentional images generated using region analysis technique. Images are tilted forward 
25° to enhance appreciation of the 3-dimensional aspects of the image.      
4.4.3 Ultrasound image characteristics of dominant follicles compared to 1st subordinate 
following OC discontinuation 
Twenty two of the 24 women evaluated (91.7%) grew a single preovulatory follicle and 
ovulated in the first cycle following OC discontinuation. The remaining 2 women formed 
hemorrhagic anovulatory follicles (HAF) and were excluded from analyses. The growth profiles of 
dominant and SF1 following OC cessation are presented (Figure 4.3: A). Physiological selection of 
the DF (as identified by its divergence in diameter from the SF1) occurred approximately 12 days 
after wave emergence following OC discontinuation (p<0.0001).  
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Spot analysis of follicle antrum: Numerical pixel values were higher in SF1 than DF 
(p<0.0001; Figure 4.3: B) which was first manifest 6 days after wave emergence. Pixel heterogeneity 
values (PH) were greater (p<0.0001; Figure 4.3: C) in the follicular fluid of SF1 compared to DF. 
The differences between antral PH were first observed (p<0.0001) 6 days after wave emergence and 
remained higher until the day of ovulation. Day effects for NPV (p<0.0031) and PH (p=0.0500) 
were significant indicating that time influenced the pixel values. Follicle by day interactions for NPV 
(p<0.0001) and PH (p<0.0001) were significant indicating that changes in antral NPV and PH over 
time were affected by the follicle type.  
Line analysis of follicle wall: Numerical pixel values for the follicle wall were higher in SF1 
(p<0.0001) compared to DF (Figure 4.3: D) starting 6 days (P=0.0005) after wave emergence and 
continuing until the day of ovulation. Follicle wall NPV progressively decreased as the DF 
approached the day of ovulation. There was a day effect of NPV (p=0.0105) indicating that time 
influenced wall NPV. Follicle wall PH (Figure 4.3: E) was higher in SF1 compared to DF 
(p<0.0001). Differences between PH of follicle walls were first detected 8 days (P=0.0205) after 
wave emergence and continued until the day of ovulation. The follicle by day interactions for NPV 
(p<0.0001) and PH (p<0.0001) indicated that the changes in NPV and PH over time were 
influenced by follicle type.  
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Figure 4.3: Mean follicle diameter (A), NPV (B), PH (C) of the antrum obtained by spot analysis, 
and NPV (D), PH (E) of the wall obtained by line analysis of the dominant (○; n=24) and 1st 
subordinate (●; n=24) follicles in the 1st wave following OC discontinuation (*=first day of 
significant difference). Data points are represented as the mean ± standard error. 
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4.5 Discussion  
There were significant differences between ultrasonographic image attributes of ovulatory 
DF of natural cycles and those that developed following OC discontinuation. Image attributes of 
DF were similar following discontinuation of continuous and conventional OC regimens. Image 
attributes of SF1 also were similar. Therefore, the primary hypothesis that ultrasonographic image 
attributes would differ between DF of natural cycles and DF of the first cycle following OC 
discontinuation was supported. The secondary hypothesis that image attributes of DF versus SF1 
would differ during the first cycle following discontinuation of continuous versus conventional OC 
regimens was not supported. These results were interpreted that exposure to exogenous steroid 
hormones in OC may affect follicular status, albeit in the same way regardless of dosing schemes.  
A short and temporary impairment of fertility have been reported in women who 
discontinued OC compared with women who stopped using non-hormonal methods of 
contraception [37-39]. There have also been concerns about association between duration, dosage, 
and schemes (conventional and continuous) of OC use and impaired fertility [37]. In the present 
study, DF that developed after OC termination showed higher values compared to DF developed 
during natural cycles. These findings were interpreted to mean that the OC-induced suppressive 
effects on the hypothalamo-hypophyseal axis continued after OC cessation may affect the follicle’s 
health. 
Follicular wave length, interval from wave emergence to divergence of DF, and interval from 
selection to ovulation were greater following OC compared to these from women in natural cycles 
in previous study from our laboratory [171]. The follicles that develop during natural cycles are 
recruited and begin to grow during the late luteal phase [209]. The longer intervals to selection, 
dominance and ovulation in follicles following OC discontinuation may be due to residual 
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suppressive effects of exogenous steroids on hypothalamus-hypophyseal axis resulting in a delay in 
follicular recruitment compared to natural cycles [171]. It is also possible that OC synchronize 
follicular wave development such that follicles are at an earlier stage of development and take longer 
to attain selection, dominance and ovulation than in natural cycles [190].  
Visual assessments of ultrasonographic images of DF developed during natural cycles and 
those of the 1st cycle fowling OC cessation were similar. The three-dimensional images created by 
region analysis technique were visually identical. However, their values obtained by region analysis 
differed. This apparent discrepancy was interpreted to mean that there are subtle image 
characteristics which cannot be detected by visual evaluation alone.      
The findings in the present experiment are in a good agreement with results from a previous 
study in our laboratory in which the image attributes of DF versus SF1 of natural cycle were 
characterized. Following OC discontinuation, follicular antra and walls exhibited greater NPV and 
PH in SF1 compared to DF and greater values also were observed in SF1 compared to DF during 
natural cycles  [136]. Similar patterns of follicular development were observed in both the OC and 
natural cycle studies; however, the changes in NPV and PH occurred at different times with higher 
values in DF which developed following OC cessation compared to those of natural cycles. The SF1 
exhibited higher values than DF in either cycle. Taken together, the findings of current study and 
previous histological studies that the DF developed following OC cessation exhibit: 1) thicker walls 
and had lower gray-scale values indicating a lower intensity seen with ultrasonography; 2) higher 
blood flow; and, 3) a lesser amount of collagen tissues, compared to SF1 as they approach to 
ovulation [104, 108, 133]. We interpreted these findings to mean that physiologic selection is a 
dynamic process that is initiated well before the time that DF can be detected by its larger diameter 
from other follicles in the cohort.  
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It is logical that the histomorphological changes which occur as follicles develop to fulfill 
their biological function are characterized in the attributes displayed in ultrasonographic images. 
During follicular regression, granulosa cells from the follicle wall are detached and released into the 
antral fluid resulting accumulation of cellular debris within the antral cavity  [101]. We observed that 
the SF1 of natural cycles and those of the cycle following OC termination demonstrated 
heterogeneous antral fluid as they start to become atretic consistent with the histological 
observations. 
Conclusion 
In summary, 3 months of conventional or continuous OC use was associated with 
quantitative echotextural changes within the wall and antrum of the DF that developed in the 1st 
wave after OC cessation. Quantitative image echotextural changes reflecting selection occurred at 
approximately the same time in natural cycles and following OC discontinuation; however, the 
values of DF developed following OC were higher than those of natural cycles. While interesting, 
the differences observed cannot completely explain the 3 month lag in fertility after OC termination. 
Further research should be performed to evaluate endocrine, histological, and imaging changes in 
follicles and oocyte viability assessment following OC discontinuation. This approach may improve 
our understanding of factors responsible for the fertility delay or increased miscarriage rate following 
OC discontinuation.  
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Chapter 5 
5. GENERAL DISCUSSION 
The studies presented in this thesis were designed to evaluate ultrasound image attributes of 
dominant and 1st subordinate ovarian follicles during human menstrual cycles using computer-
assisted echotexture analysis. The biologically important periods studied were major ovulatory and 
major anovulatory follicular waves (Chapter 3) during natural menstrual cycles and the first major 
ovulatory waves following oral contraceptive discontinuation (Chapter 4). Our results have provided 
rationale for further development of image analysis techniques as a research and clinical diagnostic 
tool. 
5.1 Ultrasound image analysis: A novel approach to understanding ovarian follicle 
physiology 
Our understanding of ovarian physiology has increased dramatically since the introduction 
of ultrasonography as a research and diagnostic tool. However, evaluating the physiological status of 
follicles at a single ultrasound examination and elucidating the mechanism and timing of physiologic 
selection have remained elusive. Serial ultrasound examinations are necessary to determine individual 
follicular growth or regression and to understand where a given follicle is in its life cycle. Similarly, 
scrutiny of ultrasound images has been limited to visual evaluation of follicles and the tissue 
characteristics associated with the state of the follicle’s viability or atresia which cannot be readily 
quantitated by the human eye.  
In 1996, immunohistochemical labelling was used to estimate quantitative characteristics of 
follicular structure in Mishan gilts. The rates of granulosa and thecal cell proliferation were estimated 
in vitro by using a thymidine analogue that is incorporated into newly synthesized DNA [210]. Since 
the in vitro technique was time consuming and impractical in human studies, a method for 
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determining a follicle’s physiologic in vivo status remains, therefore, highly desirable. In an early study 
in our labarotory, an automated computer-based method of segmentation has been applied to 
ultrasound images to help in detecting changes in follicles during development [211, 212]. Image 
segmentation is defined as the division of an image into homogeneous regions. Homogeneity can be 
defined in terms of intensity, color, reflectivity, and texture. The tissues represented in an ultrasound 
image have different textures which can be differentiated using a segmentation algorithm to partition 
the image [213]. Region growing, watershed, and multi-resolution texture analysis are three different 
segmentation methods that have been used to evaluate changes in follicles during development. 
Their disadvantages were over-segmentation, sensitivity to noise, time requirements, and poor 
detection of thin structures, such as the opposed walls of adjacent follicles [214-216].  
The ultimate goal of applying imaging techniques to ovarian biology is to develop a non-
invasive tool or method to determine the physiologic status of ovarian follicles on the basis a single 
ultrasound examination. Recently, a novel computer-assisted quantitative echotexture analysis was 
developed which offers a highly sensitive method which makes ultrasound images more readily 
appreciable. This technique allows rapid quantitation of minute variations in the images and has the 
potential to assess physiologic status of individual follicles (i.e., dominant versus subordinate, 
regressing versus growing) [108, 131] .  
There are endocrinologic differences between dominant and subordinate follicles in the 
cattle [133]. It was demonstrated that estrogen active follicles were healthy, potentially ovulatory 
follicles while estrogen inactive follicles were atretic [37, 186]. The estrogen active follicles were 
larger than the estrogen inactive follicles and had characteristics of preovulatory follicles such as: 1) 
high antral concentrations of estradiol; 2) low antral concentrations of progesterone and androgens; 
3) greater number of granulosa cells; and, 4) capacity of follicle cells to bind to LH. Estrogen 
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inactive follicles were morphologically similar to atretic follicles and exhibited: 1) low antral 
concentrations of estradiol; 2) high antral concentration of progesterone and androgens; and, 3) 
lower numbers of granulosa cells [37, 186, 217]. These types of endocrine evaluations of follicles are 
expensive to perform, require removal of the follicle from its in vivo environment and are neither 
practical nor ethical in clinical settings.  
Computer-assisted echotexture analysis was first validated in vitro using bovine ovaries by 
Singh et al. (1998)  [132, 133]. Pixel values of the follicle wall and antrum decreased in dominant 
follicles (DF) as they developed. In contrast, the pixel values in the walls of SF1 increased 
progressively. In addition, higher NPV were observed in the walls and antra of SF compared to DF. 
Significant correlations were observed between the pixel heterogeneity of the follicle antrum with 
intrafollicular 17β-estradiol and 17β-estradiol to progestrone ratio. Regressing follicles contained 
significantly higher concentrations of progesterone. The ratio of 17β-estradiol to progesterone was 
influenced by remarkable changes in 17β-estradiol concentration in the follicular fluid. Early-static 
phase dominant follicles of the first follicular wave produced less 17β-estradiol compared to the 
growing dominant follicles while growing dominant follicle, and preovulatory follicles produced 
markedly more 17β-estradiol than all other follicle types. Pixel heterogeneity (PH) of follicle wall and 
antrum increased during the late-static and regression phases. Therefore, as follicles regressed, the 
concentration of 17β-estradiol in the follicular fluid decreased and numerical values of the antra 
increased [132, 133].  
In vivo, the growing phase of DF was characterized by decreasing antral heterogeneity [135]. 
The static phase was marked by a drop in wall NPV and increasing antral PH. During regression, 
atretic follicles were characterized by high NPV of the follicle wall and a heterogeneous antrum.  
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These findings were in perfect agreement with histological assessments of preovulatory and 
atretic follicles [133, 135]. Quantitative echotexture analysis of ultrasound images reflected the 
functional and endocrine characteristics of DF and SF at specific stages of development and 
regression.  
Practical and ethical limitations prohibit the in vivo assessment of the hormonal 
microenvironment and physiologic status of follicle in humans. The only in vivo method we are really 
able to use for assessing the physiologic status of follicles remains the application of imaging 
techniques. Since there are similarities in morphology, physiological changes, and pathology of the 
ovaries in cows and women, the bovine model has been highly developed as a means for helping us 
to understand human folliculogenesis [97, 181, 218]. Based on our findings in animal studies, we 
believe that computer-assisted image analysis can be developed as a safe, effective, and non-invasive 
technology to evaluate human ovaries. Similarly the biological information gleaned from bovine 
studies is expected to migrate seamlessly to image interpretation in women. 
Histomorphological studies in rhesus monkeys, sheep, cattle, and humans have revealed that 
the walls of dominant (preovulatory) follicles consistently have the thickest theca interna and the 
greatest degree of vascularity. An extensive vascular plexus in the thecal layer of preovulatory 
follicles provides preferential delivery of gonadotropins [70, 78]. The blood is hypoechoeic and 
would therefore decrease NPV because the relative proportion of blood flow to the surrounding 
tissues influences echotexture. In bovine studies, the walls of preovulatory follicles exhibited the 
greatest vascularity and the lowest pixel values and observation were consistent with those from 
previous histomorphological studies [70, 132]. The low pixel values observed in the preovulatory 
follicle wall were attributed to increased blood flow and corresponding interstitial edema. 
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Conversely, blood flow to SF decreases during the regression phase (or atresia) which would be 
expected to result in higher pixel values.  
Time-related changes were observed in image attributes of the antrum and wall of dominant 
(DF) and first subordinate follicles (SF1) human ovarian follicles in the studies comprising this 
thesis. Growing DF were characterized by decreasing values in the follicle walls, whereas regressing 
follicles were characterized by increasing values of the wall and heterogeneity of the antrum. A 
significant histological characteristic of follicular regression is sloughing of granulosa cells from the 
follicle wall into the antral fluid. This degenerative process results in decreased numbers of granulosa 
cell layers comprising the stratum granulosum and accumulation of cellular debris within the antrum. 
Cellular debris was interpreted to be responsible for the heterogeneous pixel values observed in 
follicular fluid. Higher NPV and PH in antrum of SF compared to DF are attributed to greater 
Raleigh scatter from the granulosa cell debris [71, 208, 219, 220]. 
In addition to the precise quantitative results obtained by computer-assisted image analysis, 
we were able to visualize the numerical pixel information contained within images using a three 
dimensional region analysis and visualization technique. Images created by this method 
demonstrated that preovulatory DF had thick and sharp walls with smooth and homogenous 
follicular fluid. In contrast, SF1 had dull and irregular walls with heterogeneous antral fluid. It was 
clear in all studies that alterations in follicle image attributes were based on different functional and 
histomorphological changes in the follicles through their life cycle.  
5. 2 Ultrasound image analysis and selection of a dominant follicle 
Selection of a DF for preferential development and ovulation is arguably the most important 
event in ovarian physiology. While selection occurs during both ovulatory and anovulatory major 
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waves, ovulation has been observed only in the ovulatory major wave. It has been suggested that 
granulosa cells of DF acquire LH receptors (LHr) and increase their aromatization of androgen to 
estradiol 17β in response to LH as well as FSH [15, 221]. This level of investigation is not yet 
available with visualization technology and the exact mechanisms underlying physiological selection 
of the DF remain to be determined. In cows, the DF already has much higher concentrations of 
estradiol in follicular fluid by the time of physiological selection as manifest by divergence in 
diameter (approximately 3 times higher), and its granulosa cells produce more estradiol in vitro 
compared to the granulosa cells from SF [54, 217, 222, 223]. An in vivo study in women 
demonstrated that estradiol increases in the follicular-fluid when the DF was first identified by its 
larger diameter [43, 51].  
The wave phenomenon of folliculogenesis was first elucidated in animal models and has 
been especially well studied in the domestic animal species (bovine, ovine, equine). Bovine estrous 
cycles are comprised of 2 or 3 major waves (in which selection of DF occurs) per cycle and equine 
estrous cycles have 1 or 2 minor (in which selection of DF does not occur) or major follicle waves 
and a major ovulatory follicular wave [53, 89, 95, 96, 224]. It has now been well established that 
women develop 2 to 3 minor and major follicular waves during each menstrual cycle by studying the 
day-to-day changes in the diameter profiles of individual ovarian follicles using ultrasonography [53, 
59, 188]. The gonadotropins and ovarian steroids are ultimately responsible for regulating all of the 
events of folliculogenesis. In women and domestic animals, waves of follicular development are 
associated with changes in the reproductive hormones (estradiol, progesterone, FSH, and LH) 
during the menstrual cycle. Specifically, in women and domestic animals, all minor and major 
follicular waves were preceded by a rise in circulating concentrations of FSH [183, 188]. 
88 
 
The mechanisms of DF selection have been difficult to determine. In bovine, divergence of 
DF began when the largest follicle of the wave reached approximately 8.5 mm in diameter, about 2.5 
days after follicle wave emergence at approximately 4 mm. It appeared that biochemical selection of 
DF occurred prior to morphological selection, as evidenced by divergence in diameter between DF 
and SF1 follicles  [59]. Rivera et al. (2003) examined a group of follicles in cattle before divergence in 
follicular size. An increase in proteolytic activity in IGFBP-4/-5 (PAPP-A) and in estradiol was 
demonstrated prior to morphologic selection in the DF. It was suggested that the increased PAPP-A 
degrades IGFBP-4 and -5, freeing more IGF to act synergistically with FSH and thus increase 
estradiol production in the future DF [185]. These findings have demonstrated that the follicular 
microenvironment changes within the pre-selected DF. It can thus be speculated that the 
biochemical changes cause minute histomorphologhical changes which are not detectable by visual 
appreciation alone, but may one day be made visible with targeted image enhancement and analysis 
algorithms.  
In the follicular phase of the human menstrual cycle, the DF can be identified from its 
cohort by larger size (10 mm), higher mitotic index, and a considerable amount of estrogen in the 
follicular fluid [50, 60]. The growth and divergence in follicle diameters must now be defined by 
serial ultrasound examinations. The largest challenge to understanding when selection really occurs is 
that repeated measurements of the size and shape of follicles over several days are required to 
determine the physiological status of follicles. Based on retrospective evaluations of DF and SF1 
growth (diameter) profiles obtained in a previous study, physiological selection was defined by the 
day of divergence in diameters that occurred approximately 7 days before ovulation, when DF and 
SF1 were 10 mm and 8 mm in diameter, respectively  [53]. However, based on the image analysis 
studies comprising this thesis, selection was manifest 9 days prior to ovulation. Echotextural 
differences between the antra and walls of DF and SF1 were detected approximately 2 days before 
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the divergence in their diameters. We interpreted these results to mean that the quantitative 
echotextural changes reflective of histomorphological changes and perhaps biochemical changes 
within the follicle wall and antrum commence earlier than the time when DF are visually identified 
as different from others in their cohort by virtue of larger size.  
Image characteristics of anovulatory DF also differed quantitatively from SF1 of the same 
cohort. Attributes of the wall and antrum of the SF1 were higher compared to DF of anovulatory 
major waves. These observations were expected from the results of studying ovulatory wave 
follicles. It also reiterates and supports the notion that physiologic selection of DF occurs more than 
once per ovarian cycle. Interestingly, image characteristics of anovulatory DF antra and walls 
increased 3 days before the follicles were no longer detectable and reached the same values exhibited 
by the SF1 one day before they disappeared. These findings can be interpreted to mean that while 
DF and SF1 of anovulatory waves have different attributes at the end of their life span they both 
acquired the same atretic characteristics.  
Anovulatory and ovulatory DF revealed different image attributes in their follicle walls and 
antra. Higher values (NPV and PH) were observed in anovulatory DF compared to ovulatory DF 
which started approximately 6 to 7 days after wave emergence. This time period was comparable to 
the day that selection was detected by image analysis in major ovulatory waves. Moreover, the first 
difference in growth profile (difference in diameters) of ovulatory and anovulatory DF was observed 
approximately 6 to 7 days after wave emergence. This result was interpreted to mean that 6 to 7 days 
after wave emergence, morphological changes began in the selected follicles. That is, 6 days after 
wave emergence, anovulatory DF exhibited the histomorphologic characteristics of atretic follicles. 
It can be concluded that the image attributes of anovulatory DF were situated somewhere between 
characteristics of ovulatory DF and SF1. Therefore, up to some critical point, post-selection 
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anovulatory DF may have the capacity to develop into an ovulatory follicle, or will become atretic, 
depending on the endocrine environment. It is interesting to speculate that their fate may be 
ultimately determined by the circulating hormonal milieu or other signalling mechanisms.  
Identifying the time during the menstrual cycle when physiological selection is manifest will 
have a great impact in fertility treatment protocols as well as contraceptive regimens. From a fertility 
enhancement point of view, selection is the physiologic event which must be promoted to induce 
the synchronous development of a cohort of follicles each of which contains a competent oocyte. 
Applying stimulatory drugs prior to the time of selection would be expected to improve the ovarian 
response, increase the quality of oocytes and therefore increase probability of fertilization and 
conception in assisted reproductive technology programs. In addition, we expect that the total dose 
of FSH required to achieve multiple follicle development could be dramatically reduced for the 
assisted reproduction technologies. From a contraception point of view, selection is the physiologic 
event which must be suppressed to prevent ovulation. If no follicle is physiologically selected to gain 
ovulatory capability, then ovulation and conception cannot occur. Our work here is expected to play 
a significant role in the development of safer and more effective contraception. 
5. 3 Follicular development following oral contraceptive discontinuation 
Since oral contraceptives were introduced in 1950's, they have become the most popular 
reversible contraception method [129]. Approximately 100 million women across the world use OC 
as  a safe, effective, practical, and reversible method of contraception [225]. The numbers of women 
desiring contraception and the numbers of women who require the use of assisted reproductive 
technologies to complete their families are increasing [226]. Oral contraceptives have been 
traditionally administered in dosing schemes that mimic monthly menstruation. The conventional 
dosing regimen consists of 21 daily active pills followed by a seven day hormone-free interval (HFI). 
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The only benefit of the HFI is to increase user acceptability by allowing the physiologic event of 
menses [211]. However, Loudon et al. (1977) reported that three months of continuous OC use 
followed by a HFI thus allowing 4 menstrual periods per year was well accepted by women [204]. 
Since then, the efficacy, acceptability, and physiologic effects of continuous OC dosing schemes 
lasting 3, 6, and 12 months on follicular and endometrial development have been examined in detail 
[163, 227].  
Hormonal contraception is the only form of contraception that is designed to suppress 
folliculogenesis and ovulation and a large proportion of OC users are young women who have not 
started their families or wish better control over the spacing of their pregnancies. Therefore, 
reversibility and an easy return to fertility is essential. A review of the literature indicated that there is 
a delay in the return to fertility, but not a permanent impairment to conception in women who have 
used OC [228]. According to the literature, a 2 to 3 month delay in conception following 
discontinuation of OC is common and approximately half of all women (39%-56%) conceive within 
three months after stopping OC compared to 2/3 (54%-65%) for previous users of intrauterine 
devices, condoms, diaphragms and “other” contraceptive methods [166, 171]. The incidence of 
miscarriage also is reportedly higher in women who do conceive in the first 3 cycles following OC 
discontinuation [169, 176].   
It is suggested that FSH increased during the HFI due to loss of endocrine suppression of 
hypothalamo-pituitary axis. That is, follicular growth is initiated in the HFI. Development of 
physiologically selected DF has been observed during OC use and a proportion of these follicles 
continue preferential development to pre-ovulatory size [149, 151, 164, 196]. It has been reported 
that more than 85% of DF development is initiated during the HFI and ovulation of up to 50% of 
pre-ovulatory sized follicles may ovulate depending on the OC formulation [176, 196]. Increasing 
92 
 
the duration of active hormone administration to 24 days and shortening the HFI to 4 days with 
combined oral contraceptives resulted in greater suppression of ovarian activity compared with the 
conventional 21/7 regimen [213]. Further, ultrasonographic evaluations of follicle development 
during continuous and conventional OC use have revealed that continuous OC dosing schemes 
provide more complete ovarian suppression than conventional dosing. Birtch et al. (2006) observed 
that the number of follicles decreased slightly in continuous regimen as the duration of OC use 
increased and suggested that recruitment of fewer follicles into the growing pool occurred due to 
increased hypothalamo-hypophyseal-ovarian axis suppression with each subsequent cycle of OC 
administration [171]. Follicles that develop during OC cycles have different image attributes than 
follicles developing during natural cycles. In a previous study in our laboratory, higher value image 
attributes were observed in follicles which developed during OC cycles compared to follicles of 
natural cycles [53, 171]. We interpreted these findings to mean that follicle viability may be affected 
in previous OC users.  
Few attempts have been made to understand the physiologic mechanisms underlying the 
delay in fertility following OC discontinuation or the reasons for increased miscarriage rates when 
conception occurs immediately following OC discontinuation. Ethical boundaries in human 
experiments have limited such studies to imaging the ovaries or systemic hormonal evaluations. Our 
approach was to use computer-assisted image analysis techniques to evaluate ultrasound image 
attributes of the follicular development that occurred following discontinuation of both continuous 
and conventional dosing schemes (Chapter 4). The images can be obtained using non-invasive 
techniques and can therefore be created at any time during a study protocol; however, we are unable 
to confirm the findings using histological or other invasive techniques.  
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In our present study (Chapter 4), we hypothesized that ovulatory DF which developed 
following OC discontinuation may have different “health” status that would be reflected in their 
ultrasound image attributes when compared to DF of natural cycles. The rationale was based on 
previous findings and a detailed literature review  [190]. Our work demonstrated that the image 
attributes of DF and SF1 of the first cycle following OC discontinuation in both conventional and 
continuous dosing schemes were identical. That is, the OC dosing scheme did not affect image 
attributes differently. Higher image values were observed in antrum and wall of SF1 compared to 
DF of the first cycle following OC discontinuation irrespective of the OC regimen, which was in 
agreement with the results of the first experiment (Chapter 3). We found that values describing 
image attributes increased in SF1 compared to DF approximately 6 days after wave emergence in 
both natural and OC studies.  
Quantitative differences were detected between DF and SF1 in natural cycles (Chapter 3) 
and the cycle following OC cessation (Chapter 4) on approximately the same day after wave 
emergence. In addition, higher pixel values were observed in DF of the cycle following OC 
compared to those of natural cycles. We interpreted these observations to mean that following OC, 
suppression of the hypothalamo-hypophyseal axis causes a minor delay in follicular development 
such that follicles take longer to be selected and ovulate. Based on image characteristics of DF of the 
first cycle following OC use, it can be postulated that DF health may be compromised by exposure 
of the follicle to the OC during its early developmental stages. Since folliculogenesis is a dynamic 
process, the ovarian pool is subjected to the influence of OC hormones for the duration of OC use. 
It can be suggested that initial growth and development of primordial to Class 5 follicles within the 
ovarian medulla might be affected by different endocrine environment of the ovary during OC use. 
In natural cycles, follicular recruitment occurs on the first day of menses or one day before. The 
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longer interval to selection, dominance and ovulation in follicles following OC discontinuation may 
be due to recruitment after the comparable time point of natural cycles. After OC discontinuation, 
abnormal progesterone concentrations were observed in 40% of women following the first 
ovulation. Thus, reduced fertility following OC cessation may be due to luteal dysfunction [190]. 
Changes in image attributes of DF of natural cycles and following OC cessation demonstrate that 
the same trends and physiological events occur in the same sequence. The only difference is the 
length of each phase, wave emergence to selection or selection to ovulation, which takes longer in 
cycles following OC use than natural cycles. These results could not explain the 3 month delay in 
fertility after OC termination, but they do help us to understand the functional differences in the 
“health” of follicles that develop after OC use. 
Oocyte quality in addition to follicle structure and morphology is another important aspect 
of the return to fertility in previous OC users. Vassena et al. (2003) utilized image analysis techniques 
to assess follicle image attributes associated with oocyte competence in DF and SF in the bovine 
model. It was demonstrated that ultrasound image attributes of SF were correlated to oocyte 
competence. Higher NPV and PH were observed in the peri-follicular stroma of follicles containing 
competent oocytes compared to follicles containing incompetent oocytes [229]. Since there are 
ethical limitations in human oocyte studies, imaging techniques in concert with laboratory 
evaluations of the probability of fertilization in vitro and conception following embryo transfer 
remain the safest and most practical method for evaluation of oocyte quality and viability. The 
sensitivity of image analyses is not yet sufficient to provide information about the health and 
viability of the oocyte; however, it demonstrates promise as a non-invasive tool to assist in the 
evaluation of oocyte competence. Improvements in imaging technology will enhance oocyte 
evaluations by facilitating direct visualization. A combination of ultrasound, endocrine, histology, 
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and image analysis studies are necessary to evaluate all follicle components regarding the delay in 
fertility in previous OC users.  
A better understanding of the physiologic mechanisms underlying ovarian physiology 
increases our knowledge about how different hormones, factors, and proteins can alter reproductive 
function. These findings allow us to develop more acceptable and efficacious contraceptive 
techniques based on a woman’s individual physiologic needs, and more practical ovarian stimulation 
protocols to obtain oocytes for use in the assisted reproductive technologies to improve pregnancy 
rates during infertility treatment. Taken all together, the results reported in this thesis demonstrate 
that selection of DF is detectable earlier than the time of its divergence from its cohort using 
computer-assisted image analysis techniques. Quantitative differences between ultrasound images of 
ovulatory and anovulatory DF were evident. Ovulatory DF had the lowest value quantitative image 
attributes and the SF1 demonstrated the highest quantitative image values. Values describing image 
characteristics can be indicators of follicle’s viability and health which can then be the basis for 
further improvement of image analysis techniques to provide a safe and immediate diagnostic tool. 
DF of natural cycles and those that developed following OC discontinuation differed in their 
quantitative and qualitative image attributes. At least some aspects of the observed delay in fertility 
following OC use could potentially be attributed to a decrease in the follicles physiologic status 
associated with exposure to and possible residual effects of the exogenous steroids used in current 
OC. 
Computer-assisted image analysis of ultrasound images shows excellent promise to be 
developed into a strong diagnostic, prognostic, and research tool in the evaluation of ovarian 
physiology and pathology. There is tremendous potential for developing echotexture analyses 
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techniques to diagnose biologically important times such as selection and ovulation of DF, and to 
characterize abnormal follicles (i.e., follicular cysts, luteinized unovulated follicles).  
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5.4 Overall conclusions 
Taken together, by using computerized image enhancement and analysis algorithms, there was 
support for the hypotheses that: 
1) The follicle physiologically selected to ovulate can be identified prospectively from others in its 
cohort; 
2)  There are differences between ovulatory and anovulatory DF of major waves; and,  
3) DF of natural cycles quantitatively differs from those that develop following OC discontinuation. 
The following hypotheses were not supported:  
1) There are no differences in image attributes of dominant and SF1 of the anovulatory major 
waves; and,  
2) The ultrasonographic image attributes of dominant and SF1 may differ between the first cycles 
following discontinuation of continuous and conventional OC regimens. 
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